Zinc Oxide Nanoparticles for Selective Destruction of Tumor Cells and Potential for Drug Delivery Applications

<!DOCTYPE html> <html lang="en" > <head > <meta charset="UTF-8" /> <meta http-equiv="X-UA-Compatible" content="IE=edge" /> <meta name="HandheldFriendly" content="True" /> <meta name="MobileOptimized" content="320" /> <meta name="viewport" content="width=device-width, initial-scale=1.0" /> <link rel="stylesheet" href="/static/assets/style-70b9163a.css" /> <script type="module" crossorigin="" src="/static/assets/base_style-ec2bc71e.js"></script> <link rel="stylesheet" href="/static/assets/style-ef962842.css" /> <link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" /> <script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script> <style> @media screen and (min-width: 64em) { div.pmc-wm { background: repeat-y; background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3EAuthor Manuscript%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E"); padding-left: 3rem; } } </style> <link rel="apple-touch-icon" sizes="180x180" href="/static/img/favicons/apple-touch-icon.png" /> <link rel="icon" type="image/png" sizes="48x48" href="/static/img/favicons/favicon-48x48.png" /> <link rel="icon" type="image/png" sizes="32x32" href="/static/img/favicons/favicon-32x32.png" /> <link rel="icon" type="image/png" sizes="16x16" href="/static/img/favicons/favicon-16x16.png" /> <link rel="manifest" href="/static/img/favicons/site.webmanifest" /> <link rel="mask-icon" href="/static/img/favicons/safari-pinned-tab.svg" color="#0071bc" /> <meta name="msapplication-config" content="/static/img/favicons/browserconfig.xml" /> <meta name="theme-color" content="#ffffff" /> <title> Zinc Oxide Nanoparticles for Selective Destruction of Tumor Cells and Potential for Drug Delivery Applications - PMC </title>  <meta name="ncbi_app" content="cloudpmc-viewer" /> <meta name="ncbi_db" content="pmc" /> <meta name="ncbi_phid" content="76C115B6746880430615B6002189DB2B.m_1" />  <meta name="ncbi_pdid" content="article" /> <link rel="preconnect" href="https://www.google-analytics.com" /> <link rel="dns-prefetch" href="https://cdn.ncbi.nlm.nih.gov" /> <link rel="preconnect" href="https://code.jquery.com" /> <meta name="ncbi_domain" content="nihpa"> <meta name="ncbi_type" content="fulltext"> <meta name="ncbi_pcid" content="manuscript"> <link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2924765/"> <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"> <meta name="citation_journal_title" content="Expert opinion on drug delivery"> <meta name="citation_title" content="Zinc Oxide Nanoparticles for Selective Destruction of Tumor Cells and Potential for Drug Delivery Applications"> <meta name="citation_author" content="John W Rasmussen"> <meta name="citation_author_institution" content="Department of Biological Sciences, Boise State University, Boise, ID 83725"> <meta name="citation_author" content="Ezequiel Martinez"> <meta name="citation_author_institution" content="Department of Biological Sciences, Boise State University, Boise, ID 83725"> <meta name="citation_author" content="Panagiota Louka"> <meta name="citation_author_institution" content="Department of Biological Sciences, Boise State University, Boise, ID 83725"> <meta name="citation_author" content="Denise G Wingett"> <meta name="citation_author_institution" content="Department of Biological Sciences, Boise State University, Boise, ID 83725"> <meta name="citation_author_institution" content="Department of Medicine, Division of Gerontology and Geriatric Medicine, University of Washington, Seattle, WA 98195"> <meta name="citation_author_institution" content="MSTMRI Research Institute of St. Luke’s Regional Medical Center, Boise, ID, 83712"> <meta name="citation_publication_date" content="2010 Sep"> <meta name="citation_volume" content="7"> <meta name="citation_issue" content="9"> <meta name="citation_firstpage" content="1063"> <meta name="citation_doi" content="10.1517/17425247.2010.502560"> <meta name="citation_pmid" content="20716019"> <meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC2924765/"> <meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC2924765/"> <meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC2924765/pdf/nihms214788.pdf"> <meta name="description" content="Metal oxide nanoparticles, including zinc oxide, are versatile platforms for biomedical applications and therapeutic intervention. There is an urgent need to develop new classes of anticancer agents, and recent studies demonstrate that ZnO ..."> <meta name="og:title" content="Zinc Oxide Nanoparticles for Selective Destruction of Tumor Cells and Potential for Drug Delivery Applications"> <meta name="og:type" content="article"> <meta name="og:site_name" content="PubMed Central (PMC)"> <meta name="og:description" content="Metal oxide nanoparticles, including zinc oxide, are versatile platforms for biomedical applications and therapeutic intervention. There is an urgent need to develop new classes of anticancer agents, and recent studies demonstrate that ZnO ..."> <meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC2924765/"> <meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0"> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:site" content="@ncbi"> </head> <body > <a class="usa-skipnav " href="#main-content"> Skip to main content </a> <section class="usa-banner " aria-label="Official website of the United States government" > <div class="usa-accordion"> <header class="usa-banner__header"> <div class="usa-banner__inner"> <div class="grid-col-auto"> <img aria-hidden="true" class="usa-banner__header-flag" src="/static/img/us_flag.svg" alt="" /> </div> <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true"> <p class="usa-banner__header-text"> An official website of the United States government </p> <span class="usa-banner__header-action">Here's how you know</span> </div> <button type="button" class="usa-accordion__button usa-banner__button " aria-expanded="false" aria-controls="gov-banner-default" data-testid="storybook-django-banner" > <span class="usa-banner__button-text">Here's how you know</span> </button> </div> </header> <div class="usa-banner__content usa-accordion__content" id="gov-banner-default" hidden> <div class="grid-row grid-gap-lg"> <div class="usa-banner__guidance tablet:grid-col-6"> <img class="usa-banner__icon usa-media-block__img" src="/static/img/icon-dot-gov.svg" alt="" aria-hidden="true" /> <div class="usa-media-block__body"> <p> <strong>Official websites use .gov</strong> <br /> A <strong>.gov</strong> website belongs to an official government organization in the United States. </p> </div> </div> <div class="usa-banner__guidance tablet:grid-col-6"> <img class="usa-banner__icon usa-media-block__img" src="/static/img/icon-https.svg" alt="" aria-hidden="true" /> <div class="usa-media-block__body"> <p> <strong>Secure .gov websites use HTTPS</strong> <br /> A <strong>lock</strong> ( <span class="icon-lock"> <svg xmlns="http://www.w3.org/2000/svg" width="52" height="64" viewBox="0 0 52 64" class="usa-banner__lock-image" role="graphics-symbol" aria-labelledby="banner-lock-description" focusable="false"> <title id="banner-lock-title">Lock</title> <desc id="banner-lock-description"> Locked padlock icon </desc> <path fill="#000000" fill-rule="evenodd" d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" /> </svg> </span>) or <strong>https://</strong> means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. </p> </div> </div> </div> </div> </div> </section> <div class="usa-overlay"> </div> <header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header > <div class="ncbi-header"> <div class="ncbi-header__container"> <a class="ncbi-header__logo-container" href="/"> <img alt=" PMC home page " class="ncbi-header__logo-image" src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" /> </a>  <button type="button" class="usa-menu-btn ncbi-header__hamburger-button " aria-label="Show menu" data-testid="navMenuButton" > <svg aria-hidden="true" class="ncbi-hamburger-icon" fill="none" focusable="false" height="21" viewBox="0 0 31 21" width="31" xmlns="http://www.w3.org/2000/svg"> <path clip-rule="evenodd" d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z" fill="#F1F1F1" fill-rule="evenodd" /> </svg> </button>  <div class="ncbi-header__desktop-buttons">  <button type="button" class="usa-button usa-button--unstyled ncbi-header__desktop-button " aria-expanded="false" aria-controls="search-field-desktop-navigation" aria-label="Show search overlay" data-testid="toggleSearchPanelButton" data-toggle-search-panel-button > <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" > <use xlink:href="/static/img/sprite.svg#search" /> </svg> Search </button>  <div class="ncbi-header__login-dropdown"> <button type="button" class="usa-button usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button " aria-expanded="false" aria-controls="login-dropdown-menu" aria-label="Show login menu" data-testid="toggleLoginMenuDropdown" data-desktop-login-button > <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" > <use xlink:href="/static/img/sprite.svg#person" /> </svg> <span data-login-dropdown-text>Log in</span>  <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow> <use xlink:href="/static/img/sprite.svg#expand_less" /> </svg>  <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow> <use xlink:href="/static/img/sprite.svg#expand_more" /> </svg> </button>  <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu" id="login-dropdown-menu" data-desktop-login-menu-dropdown hidden> <li class="usa-nav__submenu-item">  <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link " > Dashboard </a> </li> <li class="usa-nav__submenu-item">  <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link " > Publications </a> </li> <li class="usa-nav__submenu-item">  <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link " > Account settings </a> </li> <li class="usa-nav__submenu-item"> <button type="button" class="usa-button usa-button--outline ncbi-header__login-dropdown-logout-button " data-testid="desktopLogoutButton" data-desktop-logout-button > Log out </button> </li> </ul> </div> </div> </div> </div>  <div class="ncbi-search-panel ncbi--show-only-at-desktop" data-testid="searchPanel" data-header-search-panel hidden> <div class="ncbi-search-panel__container"> <form action="https://www.ncbi.nlm.nih.gov/search/all/" aria-describedby="search-field-desktop-navigation-help-text" autocomplete="off" class="usa-search usa-search--big ncbi-search-panel__form" data-testid="form" method="GET" role="search"> <label class="usa-sr-only" data-testid="label" for="search-field-desktop-navigation"> Search… </label> <input class="usa-input" data-testid="textInput" id="search-field-desktop-navigation" name="term" placeholder="Search NCBI" type="search" value="" /> <button type="submit" class="usa-button " data-testid="button" > <span class="usa-search__submit-text"> Search NCBI </span> </button> </form> </div> </div> <nav aria-label="Primary navigation" class="usa-nav"> <p class="usa-sr-only" id="primary-navigation-sr-only-title"> Primary site navigation </p>  <button type="button" class="usa-nav__close ncbi-nav__close-button " aria-label="Close navigation menu" data-testid="navCloseButton" > <img src="/static/img/usa-icons/close.svg" alt="Close" /> </button>  <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6" role="search"> <label class="usa-sr-only" for="search-field"> Search </label> <input class="usa-input" id="search-field-mobile-navigation" type="search" placeholder="Search NCBI" name="search" /> <button type="submit" class="usa-button " >  <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg==" class="usa-search__submit-icon" alt="Search" /> </button> </form>   <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop" data-mobile-login-menu hidden> <p class="ncbi-nav__mobile-login-menu-status"> Logged in as: <strong class="ncbi-nav__mobile-login-menu-email" data-mobile-login-email-text></strong> </p> <ul class="usa-nav__primary usa-accordion"> <li class="usa-nav__primary-item"> <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link " > Dashboard </a> </li> <li class="usa-nav__primary-item"> <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link " > Publications </a> </li> <li class="usa-nav__primary-item"> <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link " > Account settings </a> </li> </ul> </div> <button type="button" class="usa-button ncbi-nav__mobile-login-button ncbi--hide-at-desktop " data-testid="mobileLoginButton" data-mobile-login-button > Log in </button> </nav> </header> <section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box"> <div class="pmc-nav-container"> <div class="pmc-header__bar"> <div class="pmc-header__logo"> <a href="/" title="Home" aria-label="PMC Home"></a> </div> <button type="button" class="usa-button usa-button--unstyled pmc-header__search__button" aria-label="Open search" data-ga-category="search" data-ga-action="PMC" data-ga-label="pmc_search_panel_mobile" > <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#search"></use> </svg> <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#close"></use> </svg> </button> </div> <div class="pmc-header__search"> <form class="usa-search usa-search--extra usa-search--article-right-column pmc-header__search__form" autocomplete="off" role="search"> <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label> <span class="autoComplete_wrapper flex-1"> <input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search" type="search" name="term" data-autocomplete-url="/search/autocomplete/"/> </span> <button class="usa-button" type="submit" formaction="https://www.ncbi.nlm.nih.gov/pmc/" data-ga-category="search" data-ga-action="PMC" data-ga-label="PMC_search_button" > <span class="usa-search__submit-text">Search in PMC</span> <img src="/static/img/usa-icons-bg/search--white.svg" class="usa-search__submit-icon" alt="Search" /> </button> </form> <ul class="pmc-header__search__menu"> <li> <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search"> Advanced Search </a> </li> <li> <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list"> Journal List </a> </li> <li> <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link" data-ga-label="user guide"> User Guide </a> </li> </ul> </div> </div> </section> <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="2924765"> <div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary"> <div class="grid-row"> <div class="grid-col-fill display-flex"> <div class="display-flex"> <ul class="usa-list usa-list--unstyled usa-list--horizontal"> <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob"> <button type="button" class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex" aria-label="Open resources" data-extra-class="is-visible-resources" data-ga-category="resources_accordion" data-ga-action="click" data-ga-label="mobile_icon" > <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#more_vert"></use> </svg> </button> </li> <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob"> <a href="https://doi.org/10.1517/17425247.2010.502560" class="usa-link display-flex" role="button" target="_blank" rel="noreferrer noopener" aria-label="View on publisher site" data-ga-category="actions" data-ga-action="click" data-ga-label="publisher_link_mobile" > <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#launch"></use> </svg> </a> </li> <li class="margin-right-2 mobile-lg:margin-right-4 display-flex"> <a href="pdf/nihms214788.pdf" class="usa-link display-flex" role="button" aria-label="Download PDF" data-ga-category="actions" data-ga-action="click" data-ga-label="pdf_download_mobile" > <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#file_download"></use> </svg> </a> </li> <li class="margin-right-2 mobile-lg:margin-right-4 display-flex"> <button class="usa-button usa-button--unstyled collections-dialog-trigger collections-button display-flex collections-button-empty" aria-label="Save article in MyNCBI collections." data-ga-category="actions" data-ga-action="click" data-ga-label="collections_button_mobile" data-collections-open-dialog-enabled="false" data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC2924765%2F%23open-collections-dialog" data-in-collections="false" > <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use> </svg> <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use> </svg> </button> </li> <li class="margin-right-2 mobile-lg:margin-right-4 display-flex"> <button role="button" class="usa-button usa-button--unstyled citation-dialog-trigger display-flex" aria-label="Open dialog with citation text in different styles" data-ga-category="actions" data-ga-action="open" data-ga-label="cite_mobile" data-all-citations-url="/resources/citations/2924765/" data-citation-style="nlm" data-download-format-link="/resources/citations/2924765/export/" > <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/sprite.svg#format_quote"></use> </svg> </button> </li> <li class="pmc-permalink display-flex"> <button type="button" class="usa-button usa-button--unstyled display-flex" aria-label="Show article permalink" aria-expanded="false" aria-haspopup="true" data-ga-category="actions" data-ga-action="open" data-ga-label="permalink_mobile" > <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#share"></use> </svg> </button> <div class="pmc-permalink__dropdown" hidden> <div class="pmc-permalink__dropdown__container"> <h2 class="usa-modal__heading margin-top-0 margin-bottom-2">PERMALINK</h2> <div class="pmc-permalink__dropdown__content"> <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC2924765/" aria-label="Article permalink"> <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link"> <svg class="usa-icon" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#content_copy"></use> </svg> <span class="margin-left-1">Copy</span> </button> </div> </div> </div> </li> </ul> </div> <button type="button" class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex" aria-label="Open article navigation" data-extra-class="is-visible-in-page" data-ga-category="actions" data-ga-action="open" data-ga-label="article_nav_mobile" > <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#list"></use> </svg> </button> </div> </div> </div> <div class="grid-container desktop:padding-left-6"> <div id="article-container" class="grid-row grid-gap"> <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content"> <div class="grid-container padding-left-0 padding-right-0"> <div class="grid-row desktop:margin-left-neg-6"> <div class="grid-col-12"> <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note"> As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health.<br/> Learn more: <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a> | <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/"> PMC Copyright Notice </a> </div> </div> </div> <div class="grid-row pmc-wm desktop:margin-left-neg-6">  <main id="main-content" class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0" > <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-nihpa.png" alt="NIHPA Author Manuscripts logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to NIHPA Author Manuscripts" title="Link to NIHPA Author Manuscripts" shape="default" href="https://www.hhs.gov/open/public-access-guiding-principles/index.html" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div> <div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Expert Opin Drug Deliv</button></div>. Author manuscript; available in PMC: 2011 Sep 1.</div> <div> <em>Published in final edited form as: </em>Expert Opin Drug Deliv. 2010 Sep;7(9):1063–1077. doi: <a href="https://doi.org/10.1517/17425247.2010.502560" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1517/17425247.2010.502560</a> </div> <nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu"> <li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Expert%20Opin%20Drug%20Deliv%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li> <li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Expert%20Opin%20Drug%20Deliv%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li> <li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Expert%20Opin%20Drug%20Deliv%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li> <li role="presentation"><a href="?term=%22Expert%20Opin%20Drug%20Deliv%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li> </ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs"> <hgroup><h1>Zinc Oxide Nanoparticles for Selective Destruction of Tumor Cells and Potential for Drug Delivery Applications</h1></hgroup><div class="cg p"> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rasmussen%20JW%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">John W Rasmussen</span></a><div hidden="hidden" id="id1"> <h3><span class="name western">John W Rasmussen</span></h3> <div class="p"> <sup>1</sup> Department of Biological Sciences, Boise State University, Boise, ID 83725</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rasmussen%20JW%22%5BAuthor%5D" class="usa-link"><span class="name western">John W Rasmussen</span></a> </div> </div> <sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Martinez%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Ezequiel Martinez</span></a><div hidden="hidden" id="id2"> <h3><span class="name western">Ezequiel Martinez</span></h3> <div class="p"> <sup>1</sup> Department of Biological Sciences, Boise State University, Boise, ID 83725</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Martinez%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Ezequiel Martinez</span></a> </div> </div> <sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Louka%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Panagiota Louka</span></a><div hidden="hidden" id="id3"> <h3><span class="name western">Panagiota Louka</span></h3> <div class="p"> <sup>1</sup> Department of Biological Sciences, Boise State University, Boise, ID 83725</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Louka%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Panagiota Louka</span></a> </div> </div> <sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wingett%20DG%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Denise G Wingett</span></a><div hidden="hidden" id="id4"> <h3><span class="name western">Denise G Wingett</span></h3> <div class="p"> <sup>1</sup> Department of Biological Sciences, Boise State University, Boise, ID 83725</div> <div class="p"> <sup>2</sup> Department of Medicine, Division of Gerontology and Geriatric Medicine, University of Washington, Seattle, WA 98195</div> <div class="p"> <sup>3</sup> MSTMRI Research Institute of St. Luke’s Regional Medical Center, Boise, ID, 83712</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wingett%20DG%22%5BAuthor%5D" class="usa-link"><span class="name western">Denise G Wingett</span></a> </div> </div> <sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>4</sup> </div> <ul class="d-buttons inline-list"> <li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li> <li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li> </ul> <div class="d-panels font-secondary-light"> <div id="aip_a" class="d-panel p" style="display: none"> <div class="p" id="A1"> <sup>1</sup> Department of Biological Sciences, Boise State University, Boise, ID 83725</div> <div id="A2"> <sup>2</sup> Department of Medicine, Division of Gerontology and Geriatric Medicine, University of Washington, Seattle, WA 98195</div> <div id="A3"> <sup>3</sup> MSTMRI Research Institute of St. Luke’s Regional Medical Center, Boise, ID, 83712</div> <div class="author-notes p"> <div class="fn" id="FN1"> <sup>✉</sup><p class="display-inline">Corresponding Author: Dr. Denise Wingett, Department of Biological Sciences, Boise State University, 1910 University Dr., Boise, ID 83725. Fax: +1 (208) 426-1040, Tel: +1 (208) 426-2921. <span>denisewingett@boisestate.edu</span></p> </div> <div class="fn" id="FN2"> <sup>4</sup><p class="display-inline">This work was supported in part by an NSF-MRI award (#0821233) and an NIH award (1R15CA141358-01).</p> </div> </div> </div> <div id="clp_a" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div> </div> <div>PMCID: PMC2924765 NIHMSID: NIHMS214788 PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/20716019/" class="usa-link">20716019</a> </div> <div class="ra xbox p" role="complementary" aria-label="Related or updated information about this article"><div>The publisher's version of this article is available at <a href="https://doi.org/10.1517/17425247.2010.502560" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Expert Opin Drug Deliv</a> </div></div> </div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2> <section id="S1"><h3 class="pmc_sec_title">Importance of the field</h3> <p id="P1">Metal oxide nanoparticles, including zinc oxide, are versatile platforms for biomedical applications and therapeutic intervention. There is an urgent need to develop new classes of anticancer agents, and recent studies demonstrate that ZnO nanomaterials hold considerable promise.</p></section><section id="S2"><h3 class="pmc_sec_title">Areas covered in this review</h3> <p id="P2">This review analyzes the biomedical applications of metal oxide and ZnO nanomaterials under development at the experimental, preclinical, and clinical levels. A discussion regarding the advantages, approaches, and limitations surrounding the use of metal oxide nanoparticles for cancer applications and drug delivery is presented. The scope of this article is focused on ZnO, and other metal oxide nanomaterial systems, and their proposed mechanisms of cytotoxic action, as well as current approaches to improve their targeting and cytotoxicity against cancer cells.</p></section><section id="S3"><h3 class="pmc_sec_title">Take home message</h3> <p id="P3">Through a better understanding of the mechanisms of action and cellular consequences resulting from nanoparticles interactions with cells, the inherent toxicity and selectivity of ZnO nanoparticles against cancer may be further improved to make them attractive new anti-cancer agents.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> nanoparticles, ZnO, metal oxide, cancer</p></section></section><section id="S4"><h2 class="pmc_sec_title">1. Introduction</h2> <p id="P4">Nanotechnology represents a new and enabling platform that promises to provide a broad range of novel uses and improved technologies for biological and biomedical applications. One of the reasons behind the intense interest is that nanotechnology permits the controlled synthesis of materials where at least one dimension of the structure is less than 100 nm. This ultra-small size is comparable to naturally occurring proteins and biomolecules in the cell [<a href="#R1" class="usa-link" aria-describedby="R1">1</a>], and is notably smaller than the typical diameter (~7 μm) of many human cells. The reduction of materials to the nanoscale can frequently alter their electrical, magnetic, structural, morphological, and chemical properties enabling them to interact in unique ways with cell biomolecules and enable their physical transport into the interior structures of cells. Nanoscale particles typically possess a larger percentage of atoms at the material’s surface, which can lead to increased surface reactivity [<a href="#R2" class="usa-link" aria-describedby="R2">2</a>], and can maximize their ability to be loaded with therapeutic agents to deliver them to target cells. By appropriate engineering design these nanomaterials can acquire the ability to selectively target particular types of cells or to pass through physiological barriers and penetrate deep into tumor sites.</p> <p id="P5">The application of nanotechnology to medical applications, commonly referred to as “nanomedicine”, seeks to deliver a new set of tools, devices and therapies for treatment of human disease. Nanomaterials that can act as biological mimetics, “nanomachines”, biomaterials for tissue engineering, shape-memory polymers as molecular switches, biosensors, laboratory diagnostics, and nanoscale devices for drug release, are just a few of the applications currently being explored [<a href="#R3" class="usa-link" aria-describedby="R3">3</a>–<a href="#R5" class="usa-link" aria-describedby="R5">5</a>]. Already, nanomedicine represents an emerging industry with the US National Science Foundation predicting that the market for nanotechnology containing products will reach one trillion US dollars in 10–15 years [<a href="#R6" class="usa-link" aria-describedby="R6">6</a>]. As such, there is considerable interest in the role of nanomaterials for the rational delivery and targeting of pharmaceutical and diagnostics agents for the treatment of cancer. The potential use of ZnO and other metal oxide nanoparticles in biomedical and cancer applications is gaining interest in the scientific and medical communities, largely due to the physical and chemical properties of these nanomaterials, and is the focus of this article.</p> <section id="S5"><h3 class="pmc_sec_title">1.1. Cancer Treatment Today</h3> <p id="P6">Cancer is reported as the second leading cause of death in the US and accounts for ~25% of all deaths [<a href="#R4" class="usa-link" aria-describedby="R4">4</a>]. Even more serious is the recent projection by the World Health Organization, which anticipates total cancer cases will more than double by the year 2030 from the 12.4 million new cases seen in 2008 [<a href="#R7" class="usa-link" aria-describedby="R7">7</a>]. Despite the fact that scientific understanding of the functioning of the human body at the molecular level has improved tremendously, advances in therapeutic options for cancer have lagged by comparison. Current anticancer chemotherapies based on alkylating agents, antimetabolites, biological agents, and natural products frequently fail to produce a complete anti-cancer response due to the development of drug resistance or their failure to effectively differentiate between cancerous and normal cells. This indiscriminate action frequently leads to systemic toxicity and debilitating adverse effects in normal body tissues including bone marrow function suppression, neurotoxicity, and cardiomyopathy, which greatly limits the maximal allowable dose of the chemotherapeutic drug [<a href="#R8" class="usa-link" aria-describedby="R8">8</a>,<a href="#R9" class="usa-link" aria-describedby="R9">9</a>]. In this regard, recent studies have shown that ZnO nanoparticles exhibit a high degree of cancer cell selectivity with the ability surpass the therapeutic indices of some commonly used chemotherapeutic agents in similar <em>ex vivo</em> studies [<a href="#R10" class="usa-link" aria-describedby="R10">10</a>,<a href="#R11" class="usa-link" aria-describedby="R11">11</a>]. In addition, the rapid elimination or widespread dissemination of the anti-cancer drug across non-target tissues requires drug administration in large quantities which can further complicate problems related to non-specific toxicity. Thus, there is an urgent need to develop new classes of anticancer drugs with new modes of action that better target cancer cells while sparing healthy tissues.</p></section><section id="S6"><h3 class="pmc_sec_title">1.2. Overview of Nanotechnology in Cancer Applications</h3> <p id="P7">Nanobiotechnology has been viewed as having the potential to offer a more targeted approach capable of providing significant treatment improvements for cancer patients. The underlying rationale is that reduction of materials of the nanoscale can sometimes lead to the development of new structural, physiochemical, electronic, and magnetic properties that are not present in larger bulk-sized (micron or larger) particles comprised of the same material systems. It is these new properties that can potentially lead to unique biological and medical applications. A growing number of research groups have shown that low concentrations of nanomaterials, including metal oxide nanoparticles, can kill human cancer cells while their larger micron-sized counterparts are comparatively non-toxic [<a href="#R2" class="usa-link" aria-describedby="R2">2</a>,<a href="#R10" class="usa-link" aria-describedby="R10">10</a>,<a href="#R12" class="usa-link" aria-describedby="R12">12</a>–<a href="#R16" class="usa-link" aria-describedby="R16">16</a>]. Even more compelling are recent <em>in vitro</em> observations indicating that certain types of metal oxide nanoparticles can preferentially kill cancer cells with strikingly less toxicity against normal cells [<a href="#R10" class="usa-link" aria-describedby="R10">10</a>,<a href="#R11" class="usa-link" aria-describedby="R11">11</a>]. As a natural outcropping of these studies, there is considerable interest in further improving nanoparticle specificity and anti-cancer properties by functionalizing them with antibodies or other ligands directed against cancer-associated molecules [<a href="#R17" class="usa-link" aria-describedby="R17">17</a>]. Nanomaterials are also being explored for use in intracellular delivery of DNA, RNAi, proteins, peptides and small drugs for inducing cancer cell death, as contrast agents for cancer imaging, and as platforms for targeted gene and chemotherapeutics delivery to tumor sites [<a href="#R4" class="usa-link" aria-describedby="R4">4</a>,<a href="#R17" class="usa-link" aria-describedby="R17">17</a>].</p></section></section><section id="S7"><h2 class="pmc_sec_title">2. Significance of Nanomaterial Physical Properties and Biological Applications</h2> <p id="P8">The integration of nanotechnology and biology provides the opportunity for the development of new materials in the nanometer size range that can be applied to many potential applications in clinical medicine [<a href="#R1" class="usa-link" aria-describedby="R1">1</a>,<a href="#R18" class="usa-link" aria-describedby="R18">18</a>]. The most widely studied type of nanomaterials is the nanoparticle, which is largely due to their ease and efficiency of production from a variety of materials. When reduced to the nanoscale, unique size-dependent properties of nanoparticles are manifested [<a href="#R2" class="usa-link" aria-describedby="R2">2</a>]. The principal factors believed to cause properties of nanomaterials to differ from their larger micron-sized bulk counterparts include an increase in relative surface area, a greater percentage of atoms at the material’s surface, quantum effects which can affect chemical reactivity, and other physical and chemical properties [<a href="#R2" class="usa-link" aria-describedby="R2">2</a>,<a href="#R18" class="usa-link" aria-describedby="R18">18</a>]. The positioning of the vast majority of nanostructure atoms at the material’s surface maximizes their ability to be loaded with therapeutic drugs, and to deliver these agents to target cells and tissues.</p> <p id="P9">The size of nanoparticles, which is comparable to naturally occurring biological molecules, is another feature that makes them well suited for biological applications. Their nanoscale size allows their internalization into cells, and allows them to interact with biomolecules within or on the cell surface, enabling them to potentially affect cellular responses in a dynamic and selective manner. The size of nanoparticles can facilitate their entry into tumor tissues, and their subsequent retention, by a process recognized as the enhanced permeation and retention (EPR) effect. Therapeutic approaches making use of the EPR effect are now recognized as the “gold-standard” in the design of new anti-cancer agents. The EPR phenomena can be described as a combination of “leaky” tumor blood vessels due to alterations in angiogenic regulators, enlarged gap junctions between endothelial cells, and compromised lymphatic drainage in the tumor microenvironment. This localized imbalance allows nanoparticles of certain sizes [<a href="#R19" class="usa-link" aria-describedby="R19">19</a>] to readily enter, but to be passively retained within the tumor interstitial space, thereby improving therapeutic potential. In a recent report, particles of 100–200 nm size showed a 4-fold higher rate of tumor uptake compared to particles greater than 300 nm, or less than 50 nm in size [<a href="#R20" class="usa-link" aria-describedby="R20">20</a>]. Although smaller nanoparticles don’t readily make use of the EPR/enhanced permeation and retention effect, they typically exhibit more nanotoxicity related to their larger surface area/volume ratio [<a href="#R19" class="usa-link" aria-describedby="R19">19</a>,<a href="#R20" class="usa-link" aria-describedby="R20">20</a>]. These seemingly conflicting actions with respect to nanoparticle size and anti-tumor activity can make it difficult to reliably predict nanoparticle characteristics likely to provide the best therapeutic efficacy without direct testing.</p> <p id="P10">The electrostatic nature of nanoparticles is another important consideration as electrostatic interactions between positively charged nanomaterials and target cells are believed to play an important part in cellular adhesion and uptake [<a href="#R21" class="usa-link" aria-describedby="R21">21</a>]. Compared to normal eukaryotic cells whose outer leaflet consists of neutral charged zwitterionic phospholipids [<a href="#R22" class="usa-link" aria-describedby="R22">22</a>], cancer cells frequently maintain a high concentration of anionic phospholipids on their outer leaflet and large membrane potentials [<a href="#R23" class="usa-link" aria-describedby="R23">23</a>–<a href="#R25" class="usa-link" aria-describedby="R25">25</a>], and over-express specific groups of charged proteins and carbohydrates [<a href="#R5" class="usa-link" aria-describedby="R5">5</a>]. In addition, studies have shown that intracellular pH increases with cell cycle progression and proliferation [<a href="#R26" class="usa-link" aria-describedby="R26">26</a>,<a href="#R27" class="usa-link" aria-describedby="R27">27</a>], which could affect electrostatically-driven interactions with charged particles at the cell membrane. Even more compelling is data demonstrating that while polycationic polymer particles and cationic fullerenes cause substantial disruption of biomembranes, their neutral or negatively charged counterparts fail to cause measurable effect [<a href="#R28" class="usa-link" aria-describedby="R28">28</a>]. While nanoparticles with higher positive charge may be desirable for higher toxicity to cancer cells, very high positive charge may not be suitable for <em>in vivo</em> cancer treatment due to rapid serum clearance [<a href="#R29" class="usa-link" aria-describedby="R29">29</a>]. Thus, tailoring the surface charge of nanoparticles is expected to influence their cytotoxicity and will likely be an important parameter for developing cancer therapies.</p> <p id="P11">The overall shape and morphology of the nanomaterial is another important consideration for biomedical applications. In addition to nanoparticles, which are roughly spherical in structure, there are two-dimensional thin films which have been utilized for more than 40 years. There is also a class of one-dimensional nanostructures, commonly referred to as nanowires, which have cylindrical cross-sections of less than 100 nm but can be hundreds of microns long. This later class includes the well-described carbon nanotubes, which have a hollow interior, while other types of nanowires made of other materials are frequently solid [<a href="#R30" class="usa-link" aria-describedby="R30">30</a>,<a href="#R31" class="usa-link" aria-describedby="R31">31</a>]. Other shapes of nanomaterials are emerging concurrent with technological advancements, such as tetrapod-like ZnO nanostructures[<a href="#R32" class="usa-link" aria-describedby="R32">32</a>] and are discussed later in section 5.4. Because nanoparticles can be readily and efficiently synthesized from a wide variety of materials, including semiconductors, which can participate in cellular redox-reactions and have photocatalytic activity, they are increasingly being considered for use in biomedical applications and are the focus of this review.</p></section><section id="S8"><h2 class="pmc_sec_title">3. Toxicology concerns of ZnO nanoparticles</h2> <p id="P12">Although nanoparticles of many different types of materials can be produced, compatibility issues with living cells limits the types of nanomaterials under consideration for use in biomedical applications. ZnO is considered to be a “GRAS” (<span class="text-underline">g</span>enerally <span class="text-underline">r</span>ecognized <span class="text-underline">a</span>s <span class="text-underline">s</span>afe) substance by the FDA. However, the GRAS designation most commonly refers to materials in the micron to larger size range, as even these substances when reduced to the nanoscale can develop new actions of toxicity. As a result, a detailed evaluation of nanomaterial toxicity in both <em>in vitro</em> and <em>in vivo</em> systems is needed, as well as identifying means to reduce unwanted toxicity. One common approach to increase biocompatibility and reduce particle aggregation involves coating nanoparticles with discrete sized polymers to render them less toxic, more likely to be taken up by cells, and potentially more suitable for drug delivery applications [<a href="#R33" class="usa-link" aria-describedby="R33">33</a>].</p> <p id="P13">The primary means by which inadvertent nanoparticle exposure in humans can occur is via inhalation, ingestion, or dermal contact. After gaining access to the circulatory system, nanoparticles can be distributed throughout the body and to specific organs [<a href="#R34" class="usa-link" aria-describedby="R34">34</a>,<a href="#R35" class="usa-link" aria-describedby="R35">35</a>], and taken up by cells through phagocytic or endocytic mechanisms [<a href="#R18" class="usa-link" aria-describedby="R18">18</a>]. The liver, heart, spleen, pancreas and bone all appear to be targeted sites of ZnO nanoparticles in mice [<a href="#R36" class="usa-link" aria-describedby="R36">36</a>], and inhalation of these particles in rats produces potent yet reversible pulmonary inflammation [<a href="#R37" class="usa-link" aria-describedby="R37">37</a>]. In humans, a common occupational pulmonary illness known as metal fume fever, an influenza-like illness resulting from inflammation of the respiratory track, occurs when unprotected metal workers inhale metal fumes such as zinc oxide. Another common exposure route of ZnO nanoparticles in humans occurs via topical application of sunscreens and cosmetic products which incorporates these particles due to their UV absorption and transparent properties. While there remains some concern whether ZnO nanoparticles in these products can enter the body and cause toxicity, the majority of studies indicate that ZnO nanoparticles do not penetrate the skin and cause recognizable illness [<a href="#R38" class="usa-link" aria-describedby="R38">38</a>,<a href="#R39" class="usa-link" aria-describedby="R39">39</a>].</p> <p id="P14">The mechanisms of cytotoxicity from ZnO nanoparticles are not completely understood, but generation of reactive oxygen species (ROS) is believed to be a major component. When nanoparticles interact with cells, cellular defense mechanisms are activated to minimize damage. However, if ROS production exceeds the antioxidative defensive capacity of the cell, it results in oxidative damage of biomolecules which can lead to cell death [<a href="#R40" class="usa-link" aria-describedby="R40">40</a>,<a href="#R41" class="usa-link" aria-describedby="R41">41</a>]. Nel et al. has described ROS oxidative stress as a three-tier model [<a href="#R2" class="usa-link" aria-describedby="R2">2</a>]. Tier 1 involves increases in antioxidant enzymes to start the initial antioxidant defense, followed by Tier 2 which includes an increase in potent pro-inflammatory cytokines leading to inflammation, while Tier 3 is characterized by mitochondrial perturbation resulting in cellular death by apoptosis or necrosis. All three of these levels have been observed for ZnO nanoparticles in immortalized phagocytic or bronchial epithelial cells leading to damage of lipids, proteins and DNA, increased release of lactate dehydrogenase, and death by either necrosis or apoptosis [<a href="#R2" class="usa-link" aria-describedby="R2">2</a>,<a href="#R12" class="usa-link" aria-describedby="R12">12</a>,<a href="#R37" class="usa-link" aria-describedby="R37">37</a>,<a href="#R42" class="usa-link" aria-describedby="R42">42</a>,<a href="#R43" class="usa-link" aria-describedby="R43">43</a>].</p> <p id="P15">Studies have recorded some degree of toxicity from ZnO nanoparticles in a wide array of organisms including bacteria, macroalgae, yeast, protozoa, zebrafish, and mice [<a href="#R44" class="usa-link" aria-describedby="R44">44</a>–<a href="#R47" class="usa-link" aria-describedby="R47">47</a>]. Some of this toxicity has been attributed to the potential dissolvability of ZnO nanoparticles into free Zn<sup>2+</sup> ions [<a href="#R2" class="usa-link" aria-describedby="R2">2</a>,<a href="#R48" class="usa-link" aria-describedby="R48">48</a>,<a href="#R49" class="usa-link" aria-describedby="R49">49</a>], while others reports indicate that particle dissolution into Zn<sup>2+</sup> ions is not a major mechanism of cytotoxicity [<a href="#R42" class="usa-link" aria-describedby="R42">42</a>,<a href="#R45" class="usa-link" aria-describedby="R45">45</a>,<a href="#R50" class="usa-link" aria-describedby="R50">50</a>,<a href="#R51" class="usa-link" aria-describedby="R51">51</a>]. These differences in nanoparticle dissolution properties may likely be related to differences in nanoparticle synthesis conditions and procedures. Typically, physiological levels of zinc are recognized to be important for a variety of normal growth and developmental processes, as well as regulation of the immune system by controlling the activity of many different types of enzymes including transcription factors, metalloproteinases, and polymerases [<a href="#R52" class="usa-link" aria-describedby="R52">52</a>,<a href="#R53" class="usa-link" aria-describedby="R53">53</a>]. Under normal conditions, the cell has a relatively high concentration of zinc bound to various proteins, while the level of free Zn<sup>2+</sup> ions remain very low and tightly regulated by homeostatic mechanisms [<a href="#R52" class="usa-link" aria-describedby="R52">52</a>,<a href="#R54" class="usa-link" aria-describedby="R54">54</a>]. Excess zinc can be harmful, however, with intracellular zinc accumulation implicated in neuronal toxicity and brain injury [<a href="#R55" class="usa-link" aria-describedby="R55">55</a>]. Excess zinc consumption or inhalation has also been shown to cause ataxia and metal fume fever, respectively [<a href="#R37" class="usa-link" aria-describedby="R37">37</a>]. For instances where appreciable nanoparticle dissolution can occur, such as in acidic environments including intracellular lysosomal compartments, hydrated zinc ions in conjunction with intact ZnO nanoparticles, are suggested to lead to mitochondrial damage and disruption of cellular zinc homeostasis leading to cell death. The ultimate cytoprotective or toxic roles of zinc likely reflect the route of administration and dosage, with high concentrations of zinc salt counter-ions capable of causing cell membrane damage on their own due to osmotic disruption. Nevertheless, reduction of ZnO to the nanoscale has been shown to reveal actions of toxicity that appear to preferentially target rapidly dividing cancerous cells [<a href="#R10" class="usa-link" aria-describedby="R10">10</a>,<a href="#R11" class="usa-link" aria-describedby="R11">11</a>], which could serve as a foundation for developing novel cancer therapeutics.</p></section><section id="S9"><h2 class="pmc_sec_title">4. Nanoparticles and Cancer Treatment</h2> <p id="P16">The use of nanomaterials as pharmaceutical carriers to enhance <em>in vivo</em> anti-tumor efficacy has been considered for more than 30 years [<a href="#R56" class="usa-link" aria-describedby="R56">56</a>]. The first studies on the clinical potential of nano-drug carriers as liposomes occurred in the mid-1970’s [<a href="#R57" class="usa-link" aria-describedby="R57">57</a>] where treatment of tumor bearing mice with liposome-entrapped actinomycin D was shown to significantly prolong survival. Today, the use of nanomaterials for delivery of pharmaceutical and diagnostics agents remains at the forefront of nanomedicine, where recent improvements have been described by conjugating cell specific ligands to the surface of nanoparticles resulting in greater control of drug targeting at the tissue and cellular levels, and by encapsulating drugs within nanoparticles to significantly improve drug release profiles [<a href="#R58" class="usa-link" aria-describedby="R58">58</a>–<a href="#R60" class="usa-link" aria-describedby="R60">60</a>].</p> <p id="P17">Numerous preclinical studies using nanoparticle-targeted therapies in oncology are underway, although some ideas have already been brought to the clinic (<a href="#T1" class="usa-link">Tables 1</a>–<a href="#T3" class="usa-link">3</a>). The FDA-approved Abraxane<sup>®</sup>, an albumin-paclitaxel (Taxol<sup>®</sup>) nanoparticle treatment for metastatic breast cancer has shown a promising overall response rate of 33%, compared with 19% for Taxol<sup>®</sup> alone in a randomized, open-labeled trail of 454 patients. Overall side effects were fewer with the nano-based drug even though it delivered a 50% higher dose of the active Taxol<sup>®</sup> than the conventional formulation [<a href="#R8" class="usa-link" aria-describedby="R8">8</a>]. An additional example is Myocet<sup>®</sup>, a liposomal formulation of doxorubicin that has significantly improved the therapeutic index, the ratio of the amount of an agent that causes the desired therapeutic effect to that which causes unwanted cell death, compared with conventional doxorubicin. The development of Myocet<sup>®</sup> through nanotechnology has yielded a less cardiotoxic, better tolerated, and equally efficacious doxorubicin capable of extending the therapeutic options for the management of breast cancer [<a href="#R61" class="usa-link" aria-describedby="R61">61</a>].</p> <section class="tw xbox font-sm" id="T1"><h3 class="obj_head">Table 1.</h3> <div class="caption p"><p>Cancer Nanoparticle-based therapeutics on the market *</p></div> <div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="rows"> <thead><tr> <th valign="bottom" align="left" rowspan="1" colspan="1">Product</th> <th valign="bottom" align="left" rowspan="1" colspan="1">Type of Nanomaterial</th> <th valign="bottom" align="left" rowspan="1" colspan="1">Indication</th> <th valign="bottom" align="left" rowspan="1" colspan="1">Company</th> <th valign="bottom" align="left" rowspan="1" colspan="1">Phase</th> </tr></thead> <tbody> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Abraxane </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Paclitaxel-albumin Nanoparticle</td> <td align="left" valign="top" rowspan="1" colspan="1">Lung cancer Breast cancer</td> <td align="left" valign="top" rowspan="1" colspan="1">Abraxis BioScience, AstraZeneca</td> <td align="left" valign="top" rowspan="1" colspan="1">On market</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Myocet </strong>[<a href="#R3" class="usa-link" aria-describedby="R3">3</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Liposomal doxorubicin</td> <td align="left" valign="top" rowspan="1" colspan="1">Breast cancer</td> <td align="left" valign="top" rowspan="1" colspan="1">Zeneus Pharma</td> <td align="left" valign="top" rowspan="1" colspan="1">On market</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Depocyt </strong>[<a href="#R3" class="usa-link" aria-describedby="R3">3</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Liposomal cytarabine</td> <td align="left" valign="top" rowspan="1" colspan="1">Cancer</td> <td align="left" valign="top" rowspan="1" colspan="1">SkyePharma</td> <td align="left" valign="top" rowspan="1" colspan="1">On market</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Doxil/Caelyx</strong>[<a href="#R3" class="usa-link" aria-describedby="R3">3</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Liposomal doxorubicin</td> <td align="left" valign="top" rowspan="1" colspan="1">Cancer</td> <td align="left" valign="top" rowspan="1" colspan="1">Ortho Biotech, Schering-Plough</td> <td align="left" valign="top" rowspan="1" colspan="1">On market</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>DaunoXome </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Liposomal daunorubicin</td> <td align="left" valign="top" rowspan="1" colspan="1">Cancer</td> <td align="left" valign="top" rowspan="1" colspan="1">Gilead Sciences</td> <td align="left" valign="top" rowspan="1" colspan="1">On market</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Genexol-PM </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Methoxy-PEG-poly(D, L-lactide) taxol</td> <td align="left" valign="top" rowspan="1" colspan="1">Metastatic breast cancer</td> <td align="left" valign="top" rowspan="1" colspan="1">Samyang</td> <td align="left" valign="top" rowspan="1" colspan="1">On market</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Neulasta </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">PEG–GCSF</td> <td align="left" valign="top" rowspan="1" colspan="1">Neutropenia associated with cancer chemotherapy</td> <td align="left" valign="top" rowspan="1" colspan="1">Amgen</td> <td align="left" valign="top" rowspan="1" colspan="1">On market</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Oncaspar </strong>[<a href="#R3" class="usa-link" aria-describedby="R3">3</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">PEG–L-asparaginase</td> <td align="left" valign="top" rowspan="1" colspan="1">Acute lymphoblastic leukemia</td> <td align="left" valign="top" rowspan="1" colspan="1">Enzon</td> <td align="left" valign="top" rowspan="1" colspan="1">On market</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Resovist </strong>[<a href="#R3" class="usa-link" aria-describedby="R3">3</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Iron nanoparticles</td> <td align="left" valign="top" rowspan="1" colspan="1">Liver tumor imaging</td> <td align="left" valign="top" rowspan="1" colspan="1">Schering</td> <td align="left" valign="top" rowspan="1" colspan="1">On market</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Feridex/Endorem </strong>[<a href="#R3" class="usa-link" aria-describedby="R3">3</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Iron nanoparticles</td> <td align="left" valign="top" rowspan="1" colspan="1">Liver tumor imaging</td> <td align="left" valign="top" rowspan="1" colspan="1">Advanced Magnetics, Guerbet</td> <td align="left" valign="top" rowspan="1" colspan="1">On market</td> </tr> </tbody> </table></div> <div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section class="tw xbox font-sm" id="T3"><h3 class="obj_head">Table 3.</h3> <div class="caption p"><p>Cancer Nanoparticle-based therapeutics in the preclinical development pipeline<a href="#TFN2" class="usa-link"><sup>*</sup></a></p></div> <div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="rows"> <thead><tr> <th valign="bottom" align="left" rowspan="1" colspan="1">Product/Composition</th> <th valign="bottom" align="left" rowspan="1" colspan="1">Therapeutic</th> <th valign="bottom" align="left" rowspan="1" colspan="1">Indication</th> </tr></thead> <tbody> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Auritol </strong>[<a href="#R119" class="usa-link" aria-describedby="R119">119</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Taxol and TNF α-bound colloidal gold</td> <td align="left" valign="top" rowspan="1" colspan="1">Solid tumors</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Platform technology</strong>[<a href="#R120" class="usa-link" aria-describedby="R120">120</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">PRINT<sup>™</sup> nanoparticles</td> <td align="left" valign="top" rowspan="1" colspan="1">Cancer</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>AuroLase </strong>[<a href="#R121" class="usa-link" aria-describedby="R121">121</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Gold nanoshell</td> <td align="left" valign="top" rowspan="1" colspan="1">Head and neck cancer</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Antibody–enzyme-conjugated nanoparticles </strong>[<a href="#R122" class="usa-link" aria-describedby="R122">122</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Antibody-directed enzyme prodrug therapy</td> <td align="left" valign="top" rowspan="1" colspan="1">Ovarian cancer</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Pluronic block copolymers </strong>[<a href="#R123" class="usa-link" aria-describedby="R123">123</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Doxorubicin</td> <td align="left" valign="top" rowspan="1" colspan="1">Various cancers</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Polymer–lipid hybrid nanoparticles </strong>[<a href="#R124" class="usa-link" aria-describedby="R124">124</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Doxorubicin</td> <td align="left" valign="top" rowspan="1" colspan="1">Solid tumors</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Poly(lactic-co-glycolic acid)-block-poly(ethylene glycol) </strong>[<a href="#R125" class="usa-link" aria-describedby="R125">125</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Docetaxel</td> <td align="left" valign="top" rowspan="1" colspan="1">Prostate cancers</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Poly(vinyl alcohol) polymeric micelles </strong>[<a href="#R126" class="usa-link" aria-describedby="R126">126</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">PVA polymer antitumor activity</td> <td align="left" valign="top" rowspan="1" colspan="1">Neuroblastoma, melanoma</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Folic acid-PAMAM dendrimers </strong>[<a href="#R127" class="usa-link" aria-describedby="R127">127</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Methotrexate</td> <td align="left" valign="top" rowspan="1" colspan="1">Epithelial cancer</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Poly(glycerol-succinic acid) dendrimers </strong>[<a href="#R128" class="usa-link" aria-describedby="R128">128</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Camptothecin</td> <td align="left" valign="top" rowspan="1" colspan="1">Various cancers</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Albumin-bound nanoparticles </strong>[<a href="#R129" class="usa-link" aria-describedby="R129">129</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Doxorubicin, methotrexate</td> <td align="left" valign="top" rowspan="1" colspan="1">Various cancers</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Aerosol OT (AOT)-alginate nanoparticles </strong>[<a href="#R130" class="usa-link" aria-describedby="R130">130</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Doxorubicin</td> <td align="left" valign="top" rowspan="1" colspan="1">Breast cancer</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Glycol chitosan nanoparticles </strong>[<a href="#R131" class="usa-link" aria-describedby="R131">131</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Doxorubicin</td> <td align="left" valign="top" rowspan="1" colspan="1">Solid tumors</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Gold-conjugated cytomegalovirus nanoparticles </strong>[<a href="#R132" class="usa-link" aria-describedby="R132">132</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Phototherapy, gene therapy</td> <td align="left" valign="top" rowspan="1" colspan="1">Solid tumors</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Aminosilane-coated iron oxide nanoparticles </strong>[<a href="#R65" class="usa-link" aria-describedby="R65">65</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Thermotherapy</td> <td align="left" valign="top" rowspan="1" colspan="1">Brain tumors</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Anti-HER2 antibody-targeted gold/silicon nanoparticles </strong>[<a href="#R133" class="usa-link" aria-describedby="R133">133</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Nanoshell-assisted infrared photothermal therapy</td> <td align="left" valign="top" rowspan="1" colspan="1">Metastatic breast cancer</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Silica-based nanoparticles </strong>[<a href="#R134" class="usa-link" aria-describedby="R134">134</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Photodynamic therapy</td> <td align="left" valign="top" rowspan="1" colspan="1">Various cancers</td> </tr> </tbody> </table></div> <div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div> <div class="tw-foot p"> <div class="fn" id="TFN1"><p>PEG, polyethylene glycol; GCSF, granulocyte colony-stimulating factor; HPMA, hydroxypropylmethacrylamide; DACH, diaminocyclohexane; TNF-α, tumor necrosis factor-α; HER2, human epidermal growth factor receptor 2; PAMAM, polyamidoamine; PVA, polyvinyl alcohol.</p></div> <div class="fn" id="TFN2"> <sup>*</sup><p class="display-inline">These nanoparticle-based therapeutics were selected with preference given to late-stage, preclinical, clinical, and approved products covering the wide range of modalities (e.g., liposomal platforms, dendrimers, etc) employed in the development of nanomedicines to date, and covering the broad spectrum of cancer types. This is not an exhaustive list.</p> </div> </div></section><p id="P18">In addition to nano-drug carriers, interest is growing regarding the ability of certain nanomaterials to mediate anti-cancer effects on their own, including metal oxides. One approach involves the successful use of TiO<sub>2</sub> metal oxide nanoparticles to kill cancer cells when UV irradiated [<a href="#R62" class="usa-link" aria-describedby="R62">62</a>–<a href="#R64" class="usa-link" aria-describedby="R64">64</a>]. In these studies, HeLa cells were completely killed in the presence of TiO<sub>2</sub> andUV irradiation, and <em>in vivo</em> tumor growth arrested up to 30 days, while no cancer cell killing was observed in the absence of TiO<sub>2</sub> nanoparticles and UV light. Although effective for the treatment of skin cancer, a limitation of this photodynamic nanomedicine-based approach is the inability of UV light to penetrate more than 1 mm through skin, unless fiber optics or surgery are used in conjunction.</p> <p id="P19">Nanomedicine-based hyperthermia is another promising therapy for cancer treatment. Infusing a tumor with magnetic or metal nanoparticles, and then exposing the patient to an alternating magnetic field or shortwave radiofrequency energy produces heat which warms areas immediately adjacent to the nanoparticles [<a href="#R65" class="usa-link" aria-describedby="R65">65</a>,<a href="#R66" class="usa-link" aria-describedby="R66">66</a>]. When sufficient supernormal temperatures are reached, the tumor cells are killed without harming surrounding healthy tissue. Both photodynamic and hyperthermic nanoparticle-based cancer approaches share the challenge of preferentially accumulating at tumor sites, unless targeting strategies are also employed. In addition to the above described applications, emerging approaches using zinc oxide nanoparticles are gaining interest for the development for new anti-cancer therapeutics and are described below.</p></section><section id="S10"><h2 class="pmc_sec_title">5. ZnO Nanoparticle Properties Useful for Biomedical and Cancer Applications</h2> <p id="P20">ZnO is a conventional wide band-gap semiconductor that has been highly explored in multiple areas of science. ZnO nanomaterials have been used as semiconductors in microelectronic devices and for accelerating degradation of water pollutants via photocatalytic activity. Due to its inherent ability to absorb UV irradiation and optical transparency, ZnO nanoparticles are used in the cosmetic industry, typically in sunscreens and facial creams [<a href="#R38" class="usa-link" aria-describedby="R38">38</a>,<a href="#R67" class="usa-link" aria-describedby="R67">67</a>]. Their recognized antibacterial properties are also encouraging a variety of antimicrobial applications [<a href="#R68" class="usa-link" aria-describedby="R68">68</a>,<a href="#R69" class="usa-link" aria-describedby="R69">69</a>]. ZnO nanoparticles have gained interest in other biomedical applications based on their high stability, inherent photoluminescence properties which can be useful in biosensing applications, and wide band-gap semiconductor properties useful in photocatalytic systems and promotion of reactive oxygen species generation. ZnO nanoparticles have recently shown promise as cholesterol biosensors, dietary modulators for hydrolase activity relevant to controlling diabetes and hyperlipaemia, as well as cell imaging [<a href="#R11" class="usa-link" aria-describedby="R11">11</a>,<a href="#R70" class="usa-link" aria-describedby="R70">70</a>]. Additionally, ZnO nanoparticles show promise in modulating allergic reactions via inhibition of mast cell degranulation [<a href="#R71" class="usa-link" aria-describedby="R71">71</a>]. The diversity of these activities has popularized ZnO nanomaterials in interdisciplinary research communities involving physicists, chemists, and biologists.</p> <p id="P21">Although ZnO nanoparticles have been used in the cosmetic industry for many years, they have only recently been explored for use in cancer applications or as active drugs themselves. The question arises as to what makes ZnO nanoparticles an attractive consideration. Clearly, this is not simply a matter of being able to synthesize nanoparticles, as nanoparticles of many different material systems can be produced. The practical limitation for biomedical applications largely comes down to issues of biocompatibility. In this regard, ZnO nanomaterials, at least sizes larger than 100 nm, are considered to be relatively biocompatible, with bulk ZnO being recognized as a GRAS substance by the FDA making them reasonable choices for drug delivery. ZnO nanowires have been shown to be biodegradable and to eventually dissolve into ions that can be adsorbed by the body and become part of the nutritional cycle, and thereby proposed for <em>in vivo</em> biosensing and biodetection applications [<a href="#R72" class="usa-link" aria-describedby="R72">72</a>]. The ability to synthesize ZnO into hollow nanotube-type structures [<a href="#R30" class="usa-link" aria-describedby="R30">30</a>,<a href="#R31" class="usa-link" aria-describedby="R31">31</a>] also makes them reasonable choices for drug delivery, particularly slow drug release applications.</p> <p id="P22">One of the primary advantages for considering ZnO nanoparticles for use in cancer is the inherent preferential cytotoxicity against cancer cells <em>in vitro</em> [<a href="#R10" class="usa-link" aria-describedby="R10">10</a>,<a href="#R11" class="usa-link" aria-describedby="R11">11</a>]. It is anticipated that their cancer cell selectivity may be even further improved by engineering design to minimize harmful effects to normal body cells, which has been observed to occur at very high concentrations of ZnO nanoparticles, particularly those in the smaller size range of 4–20 nm [<a href="#R73" class="usa-link" aria-describedby="R73">73</a>]. In this regard, the surface chemistry of ZnO nanoparticles readily lends them to functionalization with targeting proteins or chemical groups, and may be a key to rendering them benign to normal cells while still retaining their cancer targeting and killing properties.</p> <p id="P23">The electrostatic characteristics of ZnO nanoparticles are another useful feature for biomedical applications. Zinc oxide nanoparticles typically have neutral hydroxyl groups attached to their surface, which plays a key role in their surface charge behavior [<a href="#R74" class="usa-link" aria-describedby="R74">74</a>,<a href="#R75" class="usa-link" aria-describedby="R75">75</a>]. In aqueous medium and at high pH, the chemisorbed protons (H<sup>+</sup>) move out from the particle surface leaving a negatively charged surface with partially bonded oxygen atoms (ZnO<sup>−</sup>). At lower pH, protons from the environment are likely transferred to the particle surface, leading to a positive charge from surface ZnOH<sub>2</sub><sup>+</sup> groups. The isoelectric point of 9–10 [<a href="#R76" class="usa-link" aria-describedby="R76">76</a>] indicates that ZnO nanoparticles will have a strong positive surface charge under physiological conditions. Given that cancer cells frequently contain a high concentration of anionic phospholipids on their outer membrane and large membrane potentials [<a href="#R23" class="usa-link" aria-describedby="R23">23</a>–<a href="#R25" class="usa-link" aria-describedby="R25">25</a>], interactions with positively charged ZnO nanoparticles are expected to be driven by electrostatic interactions, thereby promoting cellular uptake, phagocytosis and ultimate cytotoxicity.</p> <p id="P24">The concentration of various chemical groups (-ZnOH<sub>2</sub><sup>+</sup>, -ZnOH, -ZnO<sup>−</sup>) on the surface of ZnO nanoparticles is pH dependent [<a href="#R77" class="usa-link" aria-describedby="R77">77</a>]. The availability of chemical reactive groups lends ZnO nanoparticles to antibody/protein functionalization via N-hydroxysuccinimide/1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide (NHS/EDC) coupling chemistry [<a href="#R78" class="usa-link" aria-describedby="R78">78</a>], as well as other standard coupling approaches, which can further improve cancer cell targeting. ZnO nanoparticles have also been shown to exhibit strong protein adsorption properties, which can be used to modulate cytotoxicity, metabolism or other cellular responses [<a href="#R79" class="usa-link" aria-describedby="R79">79</a>].</p> <p id="P25">Another important feature of ZnO nanoparticles is the relatively straightforward process that allows their size and size distribution to be controlled. Studies demonstrate that the cytotoxic properties of ZnO nanoparticles against cancerous cells is directly related to size, with smaller nanoparticles exhibiting greater toxicity [<a href="#R13" class="usa-link" aria-describedby="R13">13</a>,<a href="#R15" class="usa-link" aria-describedby="R15">15</a>,<a href="#R73" class="usa-link" aria-describedby="R73">73</a>]. By tailoring nanoparticle size, it is possible to take the greatest advantage of the EPR/enhanced permeation and retention effect for increasing intra-tumor concentrations. Another important consideration is that hydrophilic nanoparticles of 100 nm size or less tend to remain in circulation considerably longer and are more likely to avoid clearance by macrophages and rapid serum clearance by the reticuloendothelial system [<a href="#R17" class="usa-link" aria-describedby="R17">17</a>]. In contrast, particles with a preponderance of hydrophobic surfaces tend to be preferentially taken up by the liver, followed by the spleen and lungs [<a href="#R17" class="usa-link" aria-describedby="R17">17</a>]. The ability to modify the surface and electrostatic characteristics (zeta-potential) of ZnO nanoparticles is a desirable feature, as well as their spherical morphology which is well suited for removal from the blood stream by the kidneys to help avoid build up of these materials in the liver. The zeta potential of metal oxide nanoparticles can be varied from −30 mV in uncoated samples to +50 mV when coated with cationic surfactants such as CTAB (cetyltrimethyl ammonium bromide), by using different anionic, cationic and non-ionic surface groups including polymethyl methacrylate, sodium dodecyl sulfate, bovine serum albumin, and by varying reaction medium and chemical precursors [<a href="#R80" class="usa-link" aria-describedby="R80">80</a>,<a href="#R81" class="usa-link" aria-describedby="R81">81</a>]. The detailed evaluation of variations in ZnO nanoparticle electrostatic charge in <em>in vivo</em> systems is important for identifying the optimal charge needed to mediate cancer cell adhesion and cytotoxicity, yet avoid rapid circulation clearance and end-organ toxicities.</p> <p id="P26">Another feature of ZnO nanoparticles, as stated earlier, is their ability to induce reactive oxygen species (ROS) generation, which can lead to cell death when the antioxidative capacity of the cell is exceeded [<a href="#R12" class="usa-link" aria-describedby="R12">12</a>,<a href="#R41" class="usa-link" aria-describedby="R41">41</a>,<a href="#R82" class="usa-link" aria-describedby="R82">82</a>–<a href="#R84" class="usa-link" aria-describedby="R84">84</a>]. The ability of ZnO nanoparticles to generate ROS is related to their semiconductor properties. Unlike metals, which have a continuum of electronic states, the electrons in semiconductors can have energies only within certain bands. The void region which extends from the top of the filled valence band to the bottom of the vacant conduction band is called the band gap and is ~3.3 eV for crystalline ZnO [<a href="#R85" class="usa-link" aria-describedby="R85">85</a>]. Consequently, light of certain wavelengths (i.e. UV) contains sufficient energy to promote electrons (e<sup>−</sup>) to the conduction band to leave behind electron holes (h<sup>+</sup>), or unoccupied states in the valence band. Electrons and holes often recombine quickly, but can also migrate to the nanoparticle surface where they react with adsorbed species enabling 1) electrons to react with oxygen, and 2) holes to react with hydroxyl ions or water to form superoxide and hydroxyl radicals. Such photo-oxidations by ZnO have been traditionally used for photocatalytic oxidation of organic and inorganic pollutants, and sensitizers for the photodestruction of cancer cells [<a href="#R14" class="usa-link" aria-describedby="R14">14</a>,<a href="#R62" class="usa-link" aria-describedby="R62">62</a>,<a href="#R63" class="usa-link" aria-describedby="R63">63</a>] and bacteria [<a href="#R15" class="usa-link" aria-describedby="R15">15</a>] via oxidative damage. However, for nanoscale ZnO, large numbers of valence band holes and/or conduction band electrons are thought to be available to serve in redox reactions even in the absence of UV light [<a href="#R51" class="usa-link" aria-describedby="R51">51</a>]. One of the reasons is that as ZnO nanoparticle size decreases, so does the nanocrystal quality, which results in increased interstitial zinc ions and oxygen vacancies, and possibly donor/acceptor impurities [<a href="#R86" class="usa-link" aria-describedby="R86">86</a>]. These crystal defects can lead to a large number of electron-hole pairs (e<sup>−</sup> − h<sup>+</sup>). The holes are powerful oxidants and can split water molecules derived from the ZnO aqueous environment into H<sup>+</sup> and OH<sup>−</sup>. The conduction band electrons are good reducers and can move to the particle surface to react with dissolved oxygen molecules to generate superoxide radical anions (O<sub>2</sub><sup>•−</sup>), which in turn react with H<sup>+</sup> to generate (HO<sub>2</sub><sup>•</sup>) radicals. These HO<sub>2</sub><sup>•</sup> molecules can then produce hydrogen peroxide anions (HO<sub>2</sub><sup>−</sup>) following a subsequent encounter with electrons. Hydrogen peroxide anions can then react with hydrogen ions to produce hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) [<a href="#R87" class="usa-link" aria-describedby="R87">87</a>,<a href="#R88" class="usa-link" aria-describedby="R88">88</a>]. The relative positions of the band edges for the conduction and valence band for ZnO, and the redox potential for adsorbed substances provides a sufficiently large overpotential (voltage differences) to drive redox reactions and ROS generation in cellular environments [<a href="#R89" class="usa-link" aria-describedby="R89">89</a>–<a href="#R91" class="usa-link" aria-describedby="R91">91</a>]. The various ROS molecules produced in this fashion can trigger redox-cycling cascades in the cell, or on adjacent cell membranes, leading to depletion of endogenous cellular reserves of antioxidants such that irreparable oxidative damage to cells occurs.</p> <p id="P27">The doping of ZnO nanoparticles with transition metal ions has been demonstrated [<a href="#R85" class="usa-link" aria-describedby="R85">85</a>,<a href="#R92" class="usa-link" aria-describedby="R92">92</a>,<a href="#R93" class="usa-link" aria-describedby="R93">93</a>], and may be another approach to improve their therapeutic potential as transition metals can potentiate redox-cycling cascades. It is postulated that incorporation of Fe<sup>+3</sup> into the ZnO crystal lattice enhances the particle’s ability to generate ROS by catalyzing the dissociation of H<sub>2</sub>O<sub>2</sub> to a hydroxyl radical and hydroxide ion, or to a hydrogen ion and hydroperoxy radical following the Fenton’s reaction [<a href="#R94" class="usa-link" aria-describedby="R94">94</a>,<a href="#R95" class="usa-link" aria-describedby="R95">95</a>]. In support of this, recent studies have shown that Fe<sup>+3</sup> supported on bulk ZnO improves catalytic activity for H<sub>2</sub>O<sub>2</sub> production [<a href="#R87" class="usa-link" aria-describedby="R87">87</a>], and introduction of free transition metal ions can induce protein oxidation and redox state within cells [<a href="#R96" class="usa-link" aria-describedby="R96">96</a>]. Although a conflicting report suggests iron-doping of ZnO may not function in this manner [<a href="#R97" class="usa-link" aria-describedby="R97">97</a>], recent data from our laboratory is consistent with increased ROS capacity and may reflect differences in nanoparticle synthesis resulting in variations in surface structure and charge. Thus, the engineering of metal oxide nanoparticles to incorporate metal dopants may be a means to enhance ROS generation leading to improved cancer cell killing.</p> <section id="S11"><h3 class="pmc_sec_title">5.1. ZnO Nanoparticles and Cancer Cell Cytotoxicity</h3> <p id="P28">Several studies have suggested an increase in <em>in vitro</em> cytotoxicity with nanophase ZnO compared to micron-sized ZnO for several types of cancers including glioma, breast, bone, colon, and leukemias and lymphomas [<a href="#R10" class="usa-link" aria-describedby="R10">10</a>,<a href="#R11" class="usa-link" aria-describedby="R11">11</a>,<a href="#R13" class="usa-link" aria-describedby="R13">13</a>,<a href="#R98" class="usa-link" aria-describedby="R98">98</a>]. In most of these studies, however, a systematic review of cancer cell cytotoxicity compared to relevant non-immortalized cell types was not performed. Perhaps the most compelling evidence of ZnO preferential toxicity comes from controlled studies comparing nanoparticle susceptibility of cancerous cells to primary non-immortalized cells of identical lineage. These studies showed that cancerous cells of lymphocytic lineage were ~28–35 times more susceptible to ZnO nanoparticle-induced cytotoxicity compared to their normal counterparts [<a href="#R10" class="usa-link" aria-describedby="R10">10</a>,<a href="#R11" class="usa-link" aria-describedby="R11">11</a>,<a href="#R73" class="usa-link" aria-describedby="R73">73</a>]. This high degree of selective cancer cell killing exceeds the <em>ex vivo</em> therapeutic indices of ≤ 10 reported for commonly used chemotherapeutic drugs such as doxorubicin and carboplatin against a variety of leukemias, lymphomas, and solid tumors using similar biological assays. The preferential cytotoxicity was found to be dependent upon on the proliferation status of cells, with rapidly dividing cells being the most susceptible [<a href="#R10" class="usa-link" aria-describedby="R10">10</a>,<a href="#R73" class="usa-link" aria-describedby="R73">73</a>]. Based on a growing body of evidence, ROS production is proposed as a key cytotoxic mechanism of ZnO nanoparticles [<a href="#R43" class="usa-link" aria-describedby="R43">43</a>,<a href="#R43" class="usa-link" aria-describedby="R43">43</a>,<a href="#R50" class="usa-link" aria-describedby="R50">50</a>,<a href="#R73" class="usa-link" aria-describedby="R73">73</a>] leading to cell death via an apoptotic mechanism.</p> <p id="P29">Based on the self-lighting photodynamic therapy concept, photoactivation of ZnO nanoparticles is predicted to lead to greater levels of ROS release which, if effectively targeted to cancer cells, will lead to their selective destruction. Recent supporting studies have described the ability of ZnO nanoparticles conjugated to porphyrin to synergistically induce cytotoxicity in ovarian cancer upon exposure to UV A light, while little cytotoxicity was observed under dark conditions, or with UV exposure in the absence of nanoparticles [<a href="#R16" class="usa-link" aria-describedby="R16">16</a>]. Similar studies have demonstrated that co-administration of ZnO nanoparticles and the chemotherapeutic drug, daunorubicin, resulted in synergistic cytotoxic effects on leukemic cancer cells, which was further enhanced by UV irradiation [<a href="#R13" class="usa-link" aria-describedby="R13">13</a>]. Collectively, these reports indicate that photoactivation of ZnO nanoparticles conjugated to tumor ligands may be useful for the targeted destruction of cancer cells. Future efforts in this area of research are expected to investigate direct drug conjugation or encapsulation within the ZnO nanocrystal structure to further improve anti-cancer efficacy as discussed below.</p></section><section id="S12"><h3 class="pmc_sec_title">5.2. Metal Oxide Nanoparticles as Vehicles for Drug Delivery</h3> <p id="P30">The development of tumor-specific nanoparticles as vehicles for self-sustained drug delivery is currently an area of intense research with the potential to revolutionize cancer treatment. <strong>Nanotechnology may make it possible to improve the delivery of poorly water-soluble</strong> drugs, target delivery of drugs to specific cell or tissue sites, co-deliver two or more drugs, and aid in the visualization of drug site delivery by combining therapeutic agents with imaging modalities [<a href="#R99" class="usa-link" aria-describedby="R99">99</a>]. Using nanoparticles for drug delivery of anticancer agents has significant advantages including the ability to target specific locations in the body, reduce the overall amount of drug used, and the potential to reduce drug concentrations at nontarget sites resulting in fewer side effects. Recently, the use of ZnO quantum dots loaded with doxorubicin has proved to be an effective drug carrier characterized by an initial rapid drug release followed by a controlled release <em>in vitro</em> [<a href="#R100" class="usa-link" aria-describedby="R100">100</a>]. In this study, ZnO nanoparticles were encapsulated with chitosan to enhance the nanomaterial stability due to its hydrophilicity and cationic charge characteristics. Although ZnO nanomaterials have only recently been investigated for use as a drug delivery system, the feasibility of this approach has been demonstrated in related metal oxide systems. Iron oxide magnetic nanoparticles have been successfully used for loading high doses of water-insoluble anticancer agents to mediate dose-dependent anti-proliferative effects in breast and prostate cancer lines [<a href="#R101" class="usa-link" aria-describedby="R101">101</a>]. Iron oxide nanoparticles have also been used to deliver therapeutic agents by conjugation to both a chemotherapeutic agent, methotrexate, and a cancer targeting ligand, chlorotoxin [<a href="#R102" class="usa-link" aria-describedby="R102">102</a>]. These multifunctional nanoparticles showed increased cytotoxicity to tumor cells and prolonged tumor retention <em>in vivo</em>. Cerium oxide nanoparticles loaded with carboxybenzenesulfonamide have also been used to inhibit human carbonic anhydrase, a metalloenzyme associated with glaucoma, a major cause of blindness [<a href="#R103" class="usa-link" aria-describedby="R103">103</a>]. Thus, the relative biocompatibility of metal oxide nanomaterials and the ability to functionalize them with targeting moieties make them important for consideration as drug release platforms.</p></section><section id="S13"><h3 class="pmc_sec_title">5.3. Metal Oxide Nanoparticles and Tumor Imaging and Early Cancer Detection</h3> <p id="P31">Interest is growing regarding the use of ZnO and other metal oxide nanomaterials for use as biomarkers for cancer diagnosis, screening, and imaging. Recent studies have shown that ZnO nanoparticle cores capped with polymethyl methacrylate are useful in the detection of low abundant biomarkers [<a href="#R104" class="usa-link" aria-describedby="R104">104</a>]. These nanobeads work by facilitating surface absorption of peptide/proteins from cell extracts enabling increased sensitivity and accuracy of cancer biomarker detection using mass spectrometry. Using another approach, a ZnO nanorod-based cancer biomarker assay has been developed for high-throughput detection of ultralow levels of the telomerase activity for cancer diagnosis and screening [<a href="#R105" class="usa-link" aria-describedby="R105">105</a>].</p> <p id="P32">In an additional approach, multiple reports have described the successful use of iron oxide nanoparticles as contrast agents for cancer detection. Superparamagnetic oxide nanoparticles coated with a cell resistant polymer have been shown to accumulate within tumor sites via the EPR/enhanced permeation and retention effect in tumor xenograft mice model using magnetic resonance imaging [<a href="#R106" class="usa-link" aria-describedby="R106">106</a>]. In another report, the surface of nanoparticles composed of an iron oxide core and oleic acid coating were modified with various pluronic and tetronic block copolymers and shown to provide superior <em>in-vivo</em> tumor imaging properties compared to Feridex IV, a commonly used contrast agent [<a href="#R107" class="usa-link" aria-describedby="R107">107</a>]. These modified nanoparticles exhibited an extended systemic circulation half-life and reduced clearance properties allowing them to diffuse throughout the tumor vasculature to act as whole tumor contrast agents. While the superparamagnetic properties of iron oxide nanoparticles offer an advantage for magnetic resonance imaging compared to ZnO, ZnO composite nanomaterials may ultimately prove useful for tumor imaging in the future.</p></section><section id="S14"><h3 class="pmc_sec_title">5.4. Metal Oxide Nanoparticles and Targeted Gene Delivery</h3> <p id="P33">Nanoparticles are also being studied for use as vehicles for targeted gene delivery to tumor sites. One of the advantages of this approach is that the enclosure of the expression plasmid, or conjugation/absorption of the nucleic acid to the nanoparticle surface ensures safe and efficient gene delivery to the desired tissue. Another advantage relies on the capability of nanoparticles to be taken up by specific cells and internalized to the nucleus according to their surface chemistry. The feasibility of this approach has been validated by a growing number of studies including the reported <em>in vivo</em> studies demonstrating inhibition of metastasis in melanoma tumor bearing mice treated with poly-L-lysine modified iron oxide nanoparticles carrying the NM23-H1 gene [<a href="#R108" class="usa-link" aria-describedby="R108">108</a>]. These findings are consistent with reports that this gene product inhibits metastasis in certain types of cancers. A relatively new non-invasive nanoparticle vehicle called a tetrapod avoids the requirement of cellular internationalization. These nanomaterials can be made of various materials and possess four needle-shaped legs reminiscent of the mechanism by which phages deliver genetic material to bacteria. Recently, ZnO tetrapod-like nanostructures have been synthesized as novel carriers for gene delivery. These functionalized tetrapods, consisting of silica-coated amino-modified tetrapod-like ZnO nanostructures, are able to effectively bind plasmid DNA through electrostatic interactions and enhance transfection efficiency of A375 cells [<a href="#R32" class="usa-link" aria-describedby="R32">32</a>,<a href="#R109" class="usa-link" aria-describedby="R109">109</a>]. Polycation-capped ZnO quantum dots have been recently developed and shown to mediate efficient DNA transfer into COS-7 cells, and at the same time allow for real-time imaging of gene transfer [<a href="#R110" class="usa-link" aria-describedby="R110">110</a>]. Thus, with continued research, ZnO and metal oxide nanomaterials may provide an effective means for targeted gene delivery and gene silencing for next-generation cancer applications.</p></section></section><section id="S15"><h2 class="pmc_sec_title">6. ZnO Nanoparticles and Proinflammatory Cytokines</h2> <p id="P34">ZnO nanoparticle exposure has been shown to induce the production of a variety of pro-inflammatory cytokines, including TNF-α, IFN-γ and IL-12, in <em>in vitro</em> and <em>in vivo</em> pulmonary inhalation studies [<a href="#R37" class="usa-link" aria-describedby="R37">37</a>,<a href="#R73" class="usa-link" aria-describedby="R73">73</a>,<a href="#R111" class="usa-link" aria-describedby="R111">111</a>,<a href="#R112" class="usa-link" aria-describedby="R112">112</a>]. The ability of ZnO nanoparticles to induce pro-inflammatory cytokines at nanoparticle concentrations below those causing appreciable cell death suggests that, when used at appropriate concentrations, they could enhance tumor cell killing through the production of TNF-α (tumor necrosis factor), a cytokine named for its potent anti-tumor activities [<a href="#R113" class="usa-link" aria-describedby="R113">113</a>]. Nanoparticle-induced cytokines could also facilitate effective anti-cancer actions by eliciting a cytokine profile crucial for directing the development of Th1-mediated immunity [<a href="#R114" class="usa-link" aria-describedby="R114">114</a>]. The Th1 lymphocyte subset plays an essential role in enhancing the natural cytotoxic potential of natural killer cells and T cytotoxic cells against cancer cells. As high level or chronic exposure to TNF-α has been shown to produce serious detrimental effects on the host [<a href="#R113" class="usa-link" aria-describedby="R113">113</a>], the magnitude of TNF-α and other pro-inflammatory cytokines, and their delivery to tumor sites will undoubtedly be important parameters when considering ZnO nanoparticles for biomedical purposes to achieve desired therapeutic response without eliciting potential systemic damaging effects. Thus, a careful titration of ZnO nanoparticle-based therapeutic interventions may be successful in elevating a group of cytokines important for eliciting a Th1-mediated immune response with effective anti-cancer actions without exacerbating the recognized relationship between chronic inflammation and tumorigenesis.</p></section><section id="S16"><h2 class="pmc_sec_title">7. Conclusion</h2> <p id="P35">As nanotechnology increases in scale and novelty, new applications and uses are continually being discovered. Some of the most exciting advances include using nanotechnology to combat cancer. Currently, some nanobased cancer treatments are in clinical use or the development pipeline. This review has focused on ZnO nanoparticles, which have only recently begun to be investigated with respect to cancer applications. Specific properties and characteristics of ZnO nanoparticles, such as their inherent toxicity against cancerous cells, at least for cells of lymphocytic origin, their ability to induce intracellular ROS generation leading to death via an apoptotic mechanism, and their physiochemical properties leading to cellular uptake and ease of functionalization make them an appealing candidate for biomedical applications.</p></section><section id="S17"><h2 class="pmc_sec_title">8. Expert Opinion</h2> <p id="P36">Nanotechnology has already provided significant breakthroughs in medicine and cancer applications. The potential benefits of metal oxide nanomaterials for tumor imaging, controlled drug delivery, and targeted cancer cell killing can be enormous and may offer clinical therapeutic platforms that simply do not exist today. There are multiple characteristics of ZnO that make these nanomaterials attractive considerations including their versatility, relative ease of synthesis, ability to tailor their physiochemical characteristics, ability to functionalize them with chemotherapeutic drugs and cancer targeting molecules, and their desirable cancer cell cytotoxicity profile. By building upon the inherent cancer cell cytotoxicity of ZnO nanoparticles, and fine tuning their size, shape and surface properties during the synthesis process, it may be possible to identify the physiochemical properties that take the greatest advantage of the EPR/enhanced permeation and retention effect and bypass multidrug resistance of the cell membrane. Likewise, the optimum balance of cationic surface charge to encourage cell membrane interactions without promoting rapid clearance from serum by macrophages and the RES may be identified, as well as optimum morphology to increase the likelihood of recognizing specific biological targets and control blood vessel wall adhesion strength relevant to cellular internalization. It is the expectation that systematic investigations can identify ZnO nanomaterial characteristics capable of overcoming at least some of the major barriers needed for more effective cancer treatments.</p> <p id="P37">Although metal oxide nanomaterials hold potential for improving human health, there are still multiple challenges to bring these materials to the clinic. One of the obstacles is that there is current misunderstanding regarding the biological effects and cytotoxicity profiles of ZnO nanoparticles. The discrepancies in the literature are likely attributable to the lack of common understanding between life scientists and materials scientists regarding the other’s limitations and capabilities. Nanoparticles are not necessarily identical from batch-to-batch and may display alterations in surface chemistry or size distribution. Life scientists might not appreciate the difficulty in controlling the synthesis process, while nanotechnologists might not appreciate the sensitivity of mammalian cells to these variations. There is also concern that researchers may treat ZnO nanoparticles made by different synthesis methods as a single entity with insufficient regard to their potential to exert different biological responses. Other confounding factors include differences in handling, pH variations of the dispersion media, long term stability versus freshly prepared nanoparticles, impurities, humidity variations during the synthesis, and variations in aspect ratio or agglomeration potential. In sum, a lack of careful surface and physiochemical characterizations of ZnO nanoparticles has led to much of the current confusion regarding the biological responses elicited from these materials. What is needed to avoid these types of problems is a better understanding of the intersecting areas of science between nanomaterial scientists and biologists, such that collaborations allow for the effective exchange of information and methodology to advance the field.</p> <p id="P38">Currently, the work with metal oxide nanoparticles in medicine is at a preliminary stage. Nevertheless, the use of metal oxide nanomaterials represents an expanding domain for the diagnosis and treatment of cancer. Currently insufficient <em>in vivo</em> data is available to know the biological effects of these materials with respect to inflammation and functional alterations at the cellular or whole body level. There is a need to deepen this knowledge to determine if potential advantages for these nanomedicines outweigh potential dangers associated with nanotoxicity. Although ZnO nanoparticles are widely used in the cosmetic industry and evidence against skin penetration is encouraging, there remains some debate regarding epidermal penetration and lingering questions regarding the safety of these materials. Most studies have been performed <em>in vitro</em> with limited longitudinal <em>in vivo</em> studies to assess long-term effects to kidneys, liver, and spleen, and whether the particles are cleared from the body, dissolve, or remain indefinitely. As drug carriers, ZnO nanomaterials have an advantage over dissolvable polymers in that they can exist in the body for considerable periods of time. Nanoparticles can enhance the circulation half-life of drugs to several hours allowing time to reach the cancer, while single drug molecule half-lives are usually limited to a few minutes and can require repeated injections. Nanoparticle drug carriers also have the advantage of being small enough to pass through the capillaries yet large enough not to slip through endothelial gap junctions. However, ZnO nanoparticles have a potential disadvantage to build up in the body and cause organ toxicities or breakdown in unpredictable ways. The ability of ZnO nanoparticles to induce expression of proinflammatory cytokines under certain conditions also indicates that care to dosing regimens will be essential given the recognized relationship of chronic inflammation and tumorigenesis. Although it is tempting to speculate that ZnO nanomaterials may ultimately be developed into a next generation cancer treatment, clearly more data is needed to unequivocally determine their long-term health risks.</p> <p id="P39">For the <em>in vivo</em> potential of nanotechnology in cancer therapy to be fully realized, nanomaterials have to get “smarter”, meaning better able to destroy pathogenic cells while producing negligible off-target effects to normal cells and tissues. For this to occur, it is essential to gain a clear understanding of both physiochemical determinants and physiological processes, which will likely vary with respect to the type and location of the particular cancer, as well as the method of delivery into the body. The future of nanomedicine will depend upon the intelligent design of nanomaterials based around a thorough understanding of cancer biology rather than trying to force the application of popular nanomaterials, including ZnO, to cancer treatment. It is important that synergies between clinicians, biologists and material scientists be strengthened so that future research focuses on developing the tools needed by clinicians rather than what basic scientists perceive as important. An additional stumbling block is the uncertainty of whether nanotechnology-specific medical regulations will be implemented that could add further requirements to the approval process and thereby hamper the commercialization potential. Nanomedicine is still technology driven with many scientific challenges lying ahead. However, it represents a growing field with promise to address the long standing need for new and improved anti-cancer therapies.</p> <section class="bt xbox font-sm" id="BX1"><h3 class="obj_head">Article Highlights.</h3> <ul id="L1" class="list" style="list-style-type:disc"> <li><p id="P40">There is an urgent need to develop new anti-cancer agents that are better able to target cancer cells while sparing normal cells and tissues. Nanomedicine, including the use of ZnO nanoparticles, offers considerable promise in this regard.</p></li> <li><p id="P41">The development of new physical and chemical properties that can accompany reduction of materials to the nanoscale offers advantages for developing anti-cancer agents, including the ability to tailor the electrostatic properties and size of nanoparticles to promote cellular uptake and make use of the enhance permeation and retention effect (EPR) to promote intra-tumor accumulation.</p></li> <li><p id="P42">Reduction of ZnO to the nanoscale has toxicological ramifications, including the generation of reactive oxidative species, which may be exploited in combination with cancer-specific targeting strategies for developing novel therapeutics.</p></li> <li><p id="P43">There is an increasing amount of attention on nanomaterials and their successful use in cancer treatment regimens. The potential of ZnO and other metal oxide nanoparticles is beginning to be realized.</p></li> <li><p id="P44">ZnO nanoparticles have multiple properties that are useful for biomedical applications including favorable band gap, electrostatic charge, surface chemistry, and potentiation of redox-cycling cascades. Notably, ZnO nanoparticles appear to have inherent anti-cancer cytotoxicity actions.</p></li> <li><p id="P45">A variety of metal oxide nanoparticles have shown success for use as vehicles for drug delivery, targeted gene delivery, and tumor imaging. The use of metal oxide ZnO nanoparticles in these applications is beginning to be explored with some success in areas of drug carrier and targeted gene delivery.</p></li> <li><p id="P46">Careful titration of ZnO nanoparticle-based therapeutic interventions may be successful in increasing anti-tumor cytokine production and exerting cancer cell destruction, without eliciting harmful systemic proinflammatory effects.</p></li> </ul></section></section><section id="S19" class="floats-group"><section class="tw xbox font-sm" id="T2"><h2 class="obj_head">Table 2.</h2> <div class="caption p"><p>Cancer Nanoparticle-based therapeutics in the clinical development pipeline*</p></div> <div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="rows"> <thead><tr> <th valign="bottom" align="left" rowspan="1" colspan="1">Product</th> <th valign="bottom" align="left" rowspan="1" colspan="1">Type of Nanomaterial</th> <th valign="bottom" align="left" rowspan="1" colspan="1">Indication</th> <th valign="bottom" align="left" rowspan="1" colspan="1">Company</th> <th valign="bottom" align="left" rowspan="1" colspan="1">Phase</th> </tr></thead> <tbody> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Xyotax </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Polyglutamate paclitaxel</td> <td align="left" valign="top" rowspan="1" colspan="1">Non-small-cell lung cancer, ovarian cancer</td> <td align="left" valign="top" rowspan="1" colspan="1">Cell Therapeutics</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase III</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Onco TCS </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Liposomal vincristine</td> <td align="left" valign="top" rowspan="1" colspan="1">Non-Hodgkin’s lymphoma</td> <td align="left" valign="top" rowspan="1" colspan="1">Inex, Enzon</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase II/III</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>NX 211 </strong>[<a href="#R116" class="usa-link" aria-describedby="R116">116</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Liposomal lurtotecan</td> <td align="left" valign="top" rowspan="1" colspan="1">Solid tumors</td> <td align="left" valign="top" rowspan="1" colspan="1">Gilead</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase II</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Panzem NCD </strong>[<a href="#R117" class="usa-link" aria-describedby="R117">117</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">2-methoxyestradiol NanoCrystal</td> <td align="left" valign="top" rowspan="1" colspan="1">Glioblastoma</td> <td align="left" valign="top" rowspan="1" colspan="1">EntreMed</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase II</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>OSI-211 </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Liposomal lurtotecan</td> <td align="left" valign="top" rowspan="1" colspan="1">Ovarian cancer</td> <td align="left" valign="top" rowspan="1" colspan="1">OSI Pharmaceuticals</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase II</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>SLIT Cisplatin </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Liposomal cisplatin</td> <td align="left" valign="top" rowspan="1" colspan="1">Progressive osteogenic sarcoma metastatic to the lung</td> <td align="left" valign="top" rowspan="1" colspan="1">Transave</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase II</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>ProLindac </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">HPMA copolymer–DACH platinate</td> <td align="left" valign="top" rowspan="1" colspan="1">Ovarian cancers</td> <td align="left" valign="top" rowspan="1" colspan="1">Access Pharmaceuticals</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase II</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>SP1049C </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Pluronic block- copolymer doxorubicin</td> <td align="left" valign="top" rowspan="1" colspan="1">Esophageal carcinoma</td> <td align="left" valign="top" rowspan="1" colspan="1">Supratek Pharma</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase II</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Aroplatin </strong>[<a href="#R118" class="usa-link" aria-describedby="R118">118</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Liposomal platinum</td> <td align="left" valign="top" rowspan="1" colspan="1">Solid tumors</td> <td align="left" valign="top" rowspan="1" colspan="1">Antigenics</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase I/II</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Transdrug </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Poly(iso-hexyl cyanoacrylate) doxorubicin</td> <td align="left" valign="top" rowspan="1" colspan="1">Hepatocellular carcinoma</td> <td align="left" valign="top" rowspan="1" colspan="1">BioAlliance Pharma</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase I/II</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Hepacid </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">PEG–arginine deaminase</td> <td align="left" valign="top" rowspan="1" colspan="1">Hepatocellular carcinoma</td> <td align="left" valign="top" rowspan="1" colspan="1">Phoenix</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase I/II</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>CT-2106 </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Polyglutamate camptothecin</td> <td align="left" valign="top" rowspan="1" colspan="1">Colorectal and ovarian cancers</td> <td align="left" valign="top" rowspan="1" colspan="1">Cell Therapeutics</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase I/II</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Prothecan </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">PEG–camptothecin</td> <td align="left" valign="top" rowspan="1" colspan="1">Various cancers</td> <td align="left" valign="top" rowspan="1" colspan="1">Enzon</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase I/II</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Sarcodoxome </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Liposomal doxorubicin</td> <td align="left" valign="top" rowspan="1" colspan="1">Soft tissue sarcoma</td> <td align="left" valign="top" rowspan="1" colspan="1">GP-Pharm</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase I/II</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>L-Annamycin </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Liposomal annamycin</td> <td align="left" valign="top" rowspan="1" colspan="1">Acute lymphocytic leukemia, acute myeloid</td> <td align="left" valign="top" rowspan="1" colspan="1">Callisto</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase I</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Al-850 </strong>[<a href="#R3" class="usa-link" aria-describedby="R3">3</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Paclitaxel nanoparticles</td> <td align="left" valign="top" rowspan="1" colspan="1">Solid tumors</td> <td align="left" valign="top" rowspan="1" colspan="1">Acusphere</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase I</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>Aurimune </strong>[<a href="#R119" class="usa-link" aria-describedby="R119">119</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">TNF α-bound colloidal gold</td> <td align="left" valign="top" rowspan="1" colspan="1">Solid tumors</td> <td align="left" valign="top" rowspan="1" colspan="1">Cytimmune</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase I</td> </tr> <tr> <td align="left" valign="top" rowspan="1" colspan="1"> <strong>IT-101 </strong>[<a href="#R115" class="usa-link" aria-describedby="R115">115</a>]</td> <td align="left" valign="top" rowspan="1" colspan="1">Polycyclodextrin camptothecin</td> <td align="left" valign="top" rowspan="1" colspan="1">Metastatic solid tumors</td> <td align="left" valign="top" rowspan="1" colspan="1">Insert Therapeutics</td> <td align="left" valign="top" rowspan="1" colspan="1">Phase I</td> </tr> </tbody> </table></div> <div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2> <div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="FN3"> <p><strong>Declaration of interest</strong></p> <p>This work was supported in part by an NSF-MRI award (#0821233) and an NIH award (grant 1R15CA141358-01).</p> </div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">Bibliography</h2> <section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none"> <li id="R1"> <span class="label">1.</span><cite>McNeil SE. Nanotechnology for the biologist. J Leukoc Biol. 2005;78:585–94. doi: 10.1189/jlb.0205074.</cite> [<a href="https://doi.org/10.1189/jlb.0205074" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15923216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Leukoc%20Biol&title=Nanotechnology%20for%20the%20biologist&author=SE%20McNeil&volume=78&publication_year=2005&pages=585-94&pmid=15923216&doi=10.1189/jlb.0205074&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R2"> <span class="label">2••.</span><cite>Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622–7. doi: 10.1126/science.1114397. Thorough review of experimental toxicological effects from nanoparticle-treated assays including ZnO nanoparticles.</cite> [<a href="https://doi.org/10.1126/science.1114397" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16456071/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&title=Toxic%20potential%20of%20materials%20at%20the%20nanolevel&author=A%20Nel&author=T%20Xia&author=L%20Madler&author=N%20Li&volume=311&publication_year=2006&pages=622-7&pmid=16456071&doi=10.1126/science.1114397&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R3"> <span class="label">3.</span><cite>Wagner V, Dullaart A, Bock AK, Zweck A. The emerging nanomedicine landscape. Nat Biotechnol. 2006;24:1211–7. doi: 10.1038/nbt1006-1211.</cite> [<a href="https://doi.org/10.1038/nbt1006-1211" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17033654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Biotechnol&title=The%20emerging%20nanomedicine%20landscape&author=V%20Wagner&author=A%20Dullaart&author=AK%20Bock&author=A%20Zweck&volume=24&publication_year=2006&pages=1211-7&pmid=17033654&doi=10.1038/nbt1006-1211&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R4"> <span class="label">4••.</span><cite>Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005;5:161–71. doi: 10.1038/nrc1566. Review on nanomaterials for cancer treatment and therapeutics.</cite> [<a href="https://doi.org/10.1038/nrc1566" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15738981/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&title=Cancer%20nanotechnology:%20opportunities%20and%20challenges&author=M%20Ferrari&volume=5&publication_year=2005&pages=161-71&pmid=15738981&doi=10.1038/nrc1566&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R5"> <span class="label">5.</span><cite>Panchal RG. Novel therapeutic strategies to selectively kill cancer cells. Biochem Pharmacol. 1998;55:247–52. doi: 10.1016/s0006-2952(97)00240-2.</cite> [<a href="https://doi.org/10.1016/s0006-2952(97)00240-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9484789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20Pharmacol&title=Novel%20therapeutic%20strategies%20to%20selectively%20kill%20cancer%20cells&author=RG%20Panchal&volume=55&publication_year=1998&pages=247-52&pmid=9484789&doi=10.1016/s0006-2952(97)00240-2&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R6"> <span class="label">6.</span><cite>Roco MC. 2. Taylor and Francis; 2007. [Last accessed 8 June 2010]. National Nanotechnology Initiative - Past, Present, Future. Handbook on Nanoscience, Engineering and Technology. (Preprint) Available at: <a href="http://www.nano.gov/html/res/articles.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.nano.gov/html/res/articles.html</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?Roco%20MC.%202.%20Taylor%20and%20Francis;%202007.%20%5BLast%20accessed%208%20June%202010%5D.%20National%20Nanotechnology%20Initiative%20-%20Past,%20Present,%20Future.%20Handbook%20on%20Nanoscience,%20Engineering%20and%20Technology.%20(Preprint)%20Available%20at:%20www.nano.gov/html/res/articles.html." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R7"> <span class="label">7.</span><cite>Boyle P, Levin B. World Cancer Report 2008. International Agency for Research on Cancer World Health Organization; 2009. [Last accessed 8 June 2010]. Available at: <a href="http://www.iarc.fr/en/publications/pdfs-online/wcr/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.iarc.fr/en/publications/pdfs-online/wcr/</a></cite> [<a href="https://scholar.google.com/scholar_lookup?title=World%20Cancer%20Report%202008&author=P%20Boyle&author=B%20Levin&publication_year=2009&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R8"> <span class="label">8.</span><cite>Nie S, Xing Y, Kim GJ, Simons JW. Nanotechnology applications in cancer. Annu Rev Biomed Eng. 2007;9:257–88. doi: 10.1146/annurev.bioeng.9.060906.152025.</cite> [<a href="https://doi.org/10.1146/annurev.bioeng.9.060906.152025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17439359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu%20Rev%20Biomed%20Eng&title=Nanotechnology%20applications%20in%20cancer&author=S%20Nie&author=Y%20Xing&author=GJ%20Kim&author=JW%20Simons&volume=9&publication_year=2007&pages=257-88&pmid=17439359&doi=10.1146/annurev.bioeng.9.060906.152025&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R9"> <span class="label">9.</span><cite>Bosanquet AG, Bell PB. Ex vivo therapeutic index by drug sensitivity assay using fresh human normal and tumor cells. J Exp Ther Oncol. 2004;4:145–54.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/15500009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Exp%20Ther%20Oncol&title=Ex%20vivo%20therapeutic%20index%20by%20drug%20sensitivity%20assay%20using%20fresh%20human%20normal%20and%20tumor%20cells&author=AG%20Bosanquet&author=PB%20Bell&volume=4&publication_year=2004&pages=145-54&pmid=15500009&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R10"> <span class="label">10.</span><cite>Hanley C, Layne J, Punnoose A, et al. Preferential killing of cancer cells and activated human T cells using zinc oxide nanoparticles. Nanotechnology. 2008;19:295103–13. doi: 10.1088/0957-4484/19/29/295103.</cite> [<a href="https://doi.org/10.1088/0957-4484/19/29/295103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2558672/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18836572/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanotechnology&title=Preferential%20killing%20of%20cancer%20cells%20and%20activated%20human%20T%20cells%20using%20zinc%20oxide%20nanoparticles&author=C%20Hanley&author=J%20Layne&author=A%20Punnoose&volume=19&publication_year=2008&pages=295103-13&pmid=18836572&doi=10.1088/0957-4484/19/29/295103&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R11"> <span class="label">11.</span><cite>Wang H, Wingett D, Engelhard MH, et al. Fluorescent dye encapsulated ZnO particles with cell-specific toxicity for potential use in biomedical applications. J Mater Sci Mater Med. 2009;20:11–22. doi: 10.1007/s10856-008-3541-z.</cite> [<a href="https://doi.org/10.1007/s10856-008-3541-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18651111/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Mater%20Sci%20Mater%20Med&title=Fluorescent%20dye%20encapsulated%20ZnO%20particles%20with%20cell-specific%20toxicity%20for%20potential%20use%20in%20biomedical%20applications&author=H%20Wang&author=D%20Wingett&author=MH%20Engelhard&volume=20&publication_year=2009&pages=11-22&pmid=18651111&doi=10.1007/s10856-008-3541-z&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R12"> <span class="label">12.</span><cite>Xia T, Kovochich M, Brant J, et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006;6:1794–807. doi: 10.1021/nl061025k.</cite> [<a href="https://doi.org/10.1021/nl061025k" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16895376/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20Lett&title=Comparison%20of%20the%20abilities%20of%20ambient%20and%20manufactured%20nanoparticles%20to%20induce%20cellular%20toxicity%20according%20to%20an%20oxidative%20stress%20paradigm&author=T%20Xia&author=M%20Kovochich&author=J%20Brant&volume=6&publication_year=2006&pages=1794-807&pmid=16895376&doi=10.1021/nl061025k&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R13"> <span class="label">13.</span><cite>Guo D, Wu C, Jiang H, et al. Synergistic cytotoxic effect of different sized ZnO nanoparticles and daunorubicin against leukemia cancer cells under UV irradiation. J Photochem Photobiol B. 2008;93:119–26. doi: 10.1016/j.jphotobiol.2008.07.009.</cite> [<a href="https://doi.org/10.1016/j.jphotobiol.2008.07.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18774727/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Photochem%20Photobiol%20B&title=Synergistic%20cytotoxic%20effect%20of%20different%20sized%20ZnO%20nanoparticles%20and%20daunorubicin%20against%20leukemia%20cancer%20cells%20under%20UV%20irradiation&author=D%20Guo&author=C%20Wu&author=H%20Jiang&volume=93&publication_year=2008&pages=119-26&pmid=18774727&doi=10.1016/j.jphotobiol.2008.07.009&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R14"> <span class="label">14.</span><cite>Kubota Y, Shuin T, Kawasaki C, et al. Photokilling of T-24 human bladder cancer cells with titanium dioxide. Br J Cancer. 1994;70:1107–11. doi: 10.1038/bjc.1994.456.</cite> [<a href="https://doi.org/10.1038/bjc.1994.456" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2033697/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7981061/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Cancer&title=Photokilling%20of%20T-24%20human%20bladder%20cancer%20cells%20with%20titanium%20dioxide&author=Y%20Kubota&author=T%20Shuin&author=C%20Kawasaki&volume=70&publication_year=1994&pages=1107-11&pmid=7981061&doi=10.1038/bjc.1994.456&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R15"> <span class="label">15.</span><cite>Nair S, Sasidharan A, Divya Rani V, et al. Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J Mater Sci Mater Med. 2009;20:235–41. doi: 10.1007/s10856-008-3548-5.</cite> [<a href="https://doi.org/10.1007/s10856-008-3548-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18716714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Mater%20Sci%20Mater%20Med&title=Role%20of%20size%20scale%20of%20ZnO%20nanoparticles%20and%20microparticles%20on%20toxicity%20toward%20bacteria%20and%20osteoblast%20cancer%20cells&author=S%20Nair&author=A%20Sasidharan&author=V%20Divya%20Rani&volume=20&publication_year=2009&pages=235-41&pmid=18716714&doi=10.1007/s10856-008-3548-5&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R16"> <span class="label">16.</span><cite>Zhang Y, Chen W, Wang SP, et al. Phototoxicity of zinc oxide nanoparticle conjugates in human ovarian cancer. J Biomed Nanotechnol. 2008;4:432–8.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biomed%20Nanotechnol&title=Phototoxicity%20of%20zinc%20oxide%20nanoparticle%20conjugates%20in%20human%20ovarian%20cancer&author=Y%20Zhang&author=W%20Chen&author=SP%20Wang&volume=4&publication_year=2008&pages=432-8&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R17"> <span class="label">17.</span><cite>Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004;56:1649–59. doi: 10.1016/j.addr.2004.02.014.</cite> [<a href="https://doi.org/10.1016/j.addr.2004.02.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15350294/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Drug%20Deliv%20Rev&title=Nanoparticle%20and%20targeted%20systems%20for%20cancer%20therapy&author=L%20Brannon-Peppas&author=JO%20Blanchette&volume=56&publication_year=2004&pages=1649-59&pmid=15350294&doi=10.1016/j.addr.2004.02.014&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R18"> <span class="label">18.</span><cite>Lanone S, Boczkowski J. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr Mol Med. 2006;6:651–63. doi: 10.2174/156652406778195026.</cite> [<a href="https://doi.org/10.2174/156652406778195026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17022735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Mol%20Med&title=Biomedical%20applications%20and%20potential%20health%20risks%20of%20nanomaterials:%20molecular%20mechanisms&author=S%20Lanone&author=J%20Boczkowski&volume=6&publication_year=2006&pages=651-63&pmid=17022735&doi=10.2174/156652406778195026&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R19"> <span class="label">19.</span><cite>Cho K, Wang X, Nie S, et al. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 2008;14:1310–16. doi: 10.1158/1078-0432.CCR-07-1441.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-07-1441" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18316549/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=Therapeutic%20nanoparticles%20for%20drug%20delivery%20in%20cancer&author=K%20Cho&author=X%20Wang&author=S%20Nie&volume=14&publication_year=2008&pages=1310-16&pmid=18316549&doi=10.1158/1078-0432.CCR-07-1441&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R20"> <span class="label">20.</span><cite>Li SD, Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm. 2008;5:496–504. doi: 10.1021/mp800049w.</cite> [<a href="https://doi.org/10.1021/mp800049w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18611037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Pharm&title=Pharmacokinetics%20and%20biodistribution%20of%20nanoparticles&author=SD%20Li&author=L%20Huang&volume=5&publication_year=2008&pages=496-504&pmid=18611037&doi=10.1021/mp800049w&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R21"> <span class="label">21.</span><cite>Ohgaki M, Kizuki T, Katsura M, Yamashita K. Manipulation of selective cell adhesion and growth by surface charges of electrically polarized hydroxyapatite. J Biomed Mater Res. 2001;57:366–73. doi: 10.1002/1097-4636(20011205)57:3<366::aid-jbm1179>3.0.co;2-x.</cite> [<a href="https://doi.org/10.1002/1097-4636(20011205)57:3<366::aid-jbm1179>3.0.co;2-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11523031/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biomed%20Mater%20Res&title=Manipulation%20of%20selective%20cell%20adhesion%20and%20growth%20by%20surface%20charges%20of%20electrically%20polarized%20hydroxyapatite&author=M%20Ohgaki&author=T%20Kizuki&author=M%20Katsura&author=K%20Yamashita&volume=57&publication_year=2001&pages=366-73&pmid=11523031&doi=10.1002/1097-4636(20011205)57:3<366::aid-jbm1179>3.0.co;2-x&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R22"> <span class="label">22.</span><cite>Leroueil PR, Hong S, Mecke A, et al. Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face? Acc Chem Res. 2007;40:335–42. doi: 10.1021/ar600012y.</cite> [<a href="https://doi.org/10.1021/ar600012y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2551762/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17474708/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acc%20Chem%20Res&title=Nanoparticle%20interaction%20with%20biological%20membranes:%20does%20nanotechnology%20present%20a%20Janus%20face?&author=PR%20Leroueil&author=S%20Hong&author=A%20Mecke&volume=40&publication_year=2007&pages=335-42&pmid=17474708&doi=10.1021/ar600012y&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R23"> <span class="label">23.</span><cite>Abercrombie M, Ambrose EJ. The surface properties of cancer cells: a review. Cancer Res. 1962;22:525–48.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/13858936/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&title=The%20surface%20properties%20of%20cancer%20cells:%20a%20review&author=M%20Abercrombie&author=EJ%20Ambrose&volume=22&publication_year=1962&pages=525-48&pmid=13858936&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R24"> <span class="label">24.</span><cite>Bockris JOM, Habib MA. Are there electrochemical aspects of cancer? J Biol Physics. 1982;10:227–37.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Physics&title=Are%20there%20electrochemical%20aspects%20of%20cancer?&author=JOM%20Bockris&author=MA%20Habib&volume=10&publication_year=1982&pages=227-37&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R25"> <span class="label">25.</span><cite>Papo N, Shahar M, Eisenbach L, Shai Y. A novel lytic peptide composed of DL-amino acids selectively kills cancer cells in culture and in mice. J Biol Chem. 2003;278:21018–23. doi: 10.1074/jbc.M211204200.</cite> [<a href="https://doi.org/10.1074/jbc.M211204200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12646578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&title=A%20novel%20lytic%20peptide%20composed%20of%20DL-amino%20acids%20selectively%20kills%20cancer%20cells%20in%20culture%20and%20in%20mice&author=N%20Papo&author=M%20Shahar&author=L%20Eisenbach&author=Y%20Shai&volume=278&publication_year=2003&pages=21018-23&pmid=12646578&doi=10.1074/jbc.M211204200&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R26"> <span class="label">26.</span><cite>Shrode LD, Tapper H, Grinstein S. Role of intracellular pH in proliferation, transformation, and apoptosis. J Bioenerg Biomembr. 1997;29:393–99. doi: 10.1023/a:1022407116339.</cite> [<a href="https://doi.org/10.1023/a:1022407116339" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9387100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Bioenerg%20Biomembr&title=Role%20of%20intracellular%20pH%20in%20proliferation,%20transformation,%20and%20apoptosis&author=LD%20Shrode&author=H%20Tapper&author=S%20Grinstein&volume=29&publication_year=1997&pages=393-99&pmid=9387100&doi=10.1023/a:1022407116339&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R27"> <span class="label">27.</span><cite>Rich IN, Worthington-White D, Garden OA, Musk P. Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na(+)/H(+) exchanger. Blood. 2000;95:1427–34.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10666221/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&title=Apoptosis%20of%20leukemic%20cells%20accompanies%20reduction%20in%20intracellular%20pH%20after%20targeted%20inhibition%20of%20the%20Na(+)/H(+)%20exchanger&author=IN%20Rich&author=D%20Worthington-White&author=OA%20Garden&author=P%20Musk&volume=95&publication_year=2000&pages=1427-34&pmid=10666221&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R28"> <span class="label">28.</span><cite>Tang YJ, Ashcroft JM, Chen D, et al. Charge-associated effects of fullerene derivatives on microbial structural integrity and central metabolism. Nano Lett. 2007;7:754–60. doi: 10.1021/nl063020t.</cite> [<a href="https://doi.org/10.1021/nl063020t" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17288489/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20Lett&title=Charge-associated%20effects%20of%20fullerene%20derivatives%20on%20microbial%20structural%20integrity%20and%20central%20metabolism&author=YJ%20Tang&author=JM%20Ashcroft&author=D%20Chen&volume=7&publication_year=2007&pages=754-60&pmid=17288489&doi=10.1021/nl063020t&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R29"> <span class="label">29.</span><cite>Xu P, Van Kirk EA, Zhan Y, et al. Targeted charge-reversal nanoparticles for nuclear drug delivery. Angew Chem Int Ed Engl. 2007;46:4999–5002. doi: 10.1002/anie.200605254.</cite> [<a href="https://doi.org/10.1002/anie.200605254" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17526044/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Angew%20Chem%20Int%20Ed%20Engl&title=Targeted%20charge-reversal%20nanoparticles%20for%20nuclear%20drug%20delivery&author=P%20Xu&author=EA%20Van%20Kirk&author=Y%20Zhan&volume=46&publication_year=2007&pages=4999-5002&pmid=17526044&doi=10.1002/anie.200605254&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R30"> <span class="label">30.</span><cite>Wang RM, Xing YJ, Yu DP. Fabrication and microstructure analysis on zinc oxide nanotubes. New J Physics. 2003;5:115–7.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=New%20J%20Physics&title=Fabrication%20and%20microstructure%20analysis%20on%20zinc%20oxide%20nanotubes&author=RM%20Wang&author=YJ%20Xing&author=DP%20Yu&volume=5&publication_year=2003&pages=115-7&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R31"> <span class="label">31.</span><cite>Wu HQ, Wei XW, Shao MW, Gu JS. Synthesis of zinc oxide nanorods using carbon nanotubes as templates. J Crystal Growth. 2004;265:184–9.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Crystal%20Growth&title=Synthesis%20of%20zinc%20oxide%20nanorods%20using%20carbon%20nanotubes%20as%20templates&author=HQ%20Wu&author=XW%20Wei&author=MW%20Shao&author=JS%20Gu&volume=265&publication_year=2004&pages=184-9&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R32"> <span class="label">32.</span><cite>Nie L, Gao L, Feng P, et al. Three-dimensional functionalized tetrapod-like ZnO nanostructures for plasmid DNA delivery. Small. 2006;2:621–5. doi: 10.1002/smll.200500193.</cite> [<a href="https://doi.org/10.1002/smll.200500193" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17193097/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Small&title=Three-dimensional%20functionalized%20tetrapod-like%20ZnO%20nanostructures%20for%20plasmid%20DNA%20delivery&author=L%20Nie&author=L%20Gao&author=P%20Feng&volume=2&publication_year=2006&pages=621-5&pmid=17193097&doi=10.1002/smll.200500193&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R33"> <span class="label">33.</span><cite>Hafeli UO, Riffle JS, Harris-Shekhawat L, et al. Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol Pharm. 2009;6:1417–28. doi: 10.1021/mp900083m.</cite> [<a href="https://doi.org/10.1021/mp900083m" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19445482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Pharm&title=Cell%20uptake%20and%20in%20vitro%20toxicity%20of%20magnetic%20nanoparticles%20suitable%20for%20drug%20delivery&author=UO%20Hafeli&author=JS%20Riffle&author=L%20Harris-Shekhawat&volume=6&publication_year=2009&pages=1417-28&pmid=19445482&doi=10.1021/mp900083m&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R34"> <span class="label">34.</span><cite>Hagens WI, Oomen AG, de Jong WH, et al. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol. 2007;49:217–29. doi: 10.1016/j.yrtph.2007.07.006.</cite> [<a href="https://doi.org/10.1016/j.yrtph.2007.07.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17868963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Regul%20Toxicol%20Pharmacol&title=What%20do%20we%20(need%20to)%20know%20about%20the%20kinetic%20properties%20of%20nanoparticles%20in%20the%20body?&author=WI%20Hagens&author=AG%20Oomen&author=WH%20de%20Jong&volume=49&publication_year=2007&pages=217-29&pmid=17868963&doi=10.1016/j.yrtph.2007.07.006&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R35"> <span class="label">35.</span><cite>Takenaka S, Karg E, Roth C, et al. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect. 2001;109(Suppl 4):547–551. doi: 10.1289/ehp.01109s4547.</cite> [<a href="https://doi.org/10.1289/ehp.01109s4547" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1240579/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11544161/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Environ%20Health%20Perspect&title=Pulmonary%20and%20systemic%20distribution%20of%20inhaled%20ultrafine%20silver%20particles%20in%20rats&author=S%20Takenaka&author=E%20Karg&author=C%20Roth&volume=109&issue=Suppl%204&publication_year=2001&pages=547-551&pmid=11544161&doi=10.1289/ehp.01109s4547&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R36"> <span class="label">36.</span><cite>Wang B, Feng W, Wang M, et al. Acute toxicological impact of nano- and submicro-scaled zinc oxide powder on healthy adult mice. J Nanopart Res. 2008;10:263–76.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Nanopart%20Res&title=Acute%20toxicological%20impact%20of%20nano-%20and%20submicro-scaled%20zinc%20oxide%20powder%20on%20healthy%20adult%20mice&author=B%20Wang&author=W%20Feng&author=M%20Wang&volume=10&publication_year=2008&pages=263-76&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R37"> <span class="label">37.</span><cite>Sayes CM, Reed KL, Warheit DB. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci. 2007;97:163–80. doi: 10.1093/toxsci/kfm018.</cite> [<a href="https://doi.org/10.1093/toxsci/kfm018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17301066/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol%20Sci&title=Assessing%20toxicity%20of%20fine%20and%20nanoparticles:%20comparing%20in%20vitro%20measurements%20to%20in%20vivo%20pulmonary%20toxicity%20profiles&author=CM%20Sayes&author=KL%20Reed&author=DB%20Warheit&volume=97&publication_year=2007&pages=163-80&pmid=17301066&doi=10.1093/toxsci/kfm018&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R38"> <span class="label">38.</span><cite>Nohynek GJ, Dufour EK, Roberts MS. Nanotechnology, cosmetics and the skin: is there a health risk? Skin Pharmacol Physiol. 2008;21:136–49. doi: 10.1159/000131078.</cite> [<a href="https://doi.org/10.1159/000131078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18523411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Skin%20Pharmacol%20Physiol&title=Nanotechnology,%20cosmetics%20and%20the%20skin:%20is%20there%20a%20health%20risk?&author=GJ%20Nohynek&author=EK%20Dufour&author=MS%20Roberts&volume=21&publication_year=2008&pages=136-49&pmid=18523411&doi=10.1159/000131078&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R39"> <span class="label">39.</span><cite>Zvyagin AV, Zhao X, Gierden A, et al. Imaging of zinc oxide nanoparticle penetration in human skin in vitro and in vivo. J Biomed Opt. 2008;13:064031–9. doi: 10.1117/1.3041492.</cite> [<a href="https://doi.org/10.1117/1.3041492" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19123677/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biomed%20Opt&title=Imaging%20of%20zinc%20oxide%20nanoparticle%20penetration%20in%20human%20skin%20in%20vitro%20and%20in%20vivo&author=AV%20Zvyagin&author=X%20Zhao&author=A%20Gierden&volume=13&publication_year=2008&pages=064031-9&pmid=19123677&doi=10.1117/1.3041492&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R40"> <span class="label">40.</span><cite>Carmody RJ, Cotter TG. Signaling apoptosis: a radical approach. Redox Rep. 2001;6:77–90. doi: 10.1179/135100001101536085.</cite> [<a href="https://doi.org/10.1179/135100001101536085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11450987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Redox%20Rep&title=Signaling%20apoptosis:%20a%20radical%20approach&author=RJ%20Carmody&author=TG%20Cotter&volume=6&publication_year=2001&pages=77-90&pmid=11450987&doi=10.1179/135100001101536085&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R41"> <span class="label">41.</span><cite>Ryter SW, Kim HP, Hoetzel A, et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal. 2007;9:49–89. doi: 10.1089/ars.2007.9.49.</cite> [<a href="https://doi.org/10.1089/ars.2007.9.49" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17115887/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antioxid%20Redox%20Signal&title=Mechanisms%20of%20cell%20death%20in%20oxidative%20stress&author=SW%20Ryter&author=HP%20Kim&author=A%20Hoetzel&volume=9&publication_year=2007&pages=49-89&pmid=17115887&doi=10.1089/ars.2007.9.49&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R42"> <span class="label">42.</span><cite>Lin W, Xu Y, Huang CC, et al. Toxicity of nano- and micro-sized ZnO particles in human lung epithelial cells. J Nanopart Res. 2009;11:25–39.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Nanopart%20Res&title=Toxicity%20of%20nano-%20and%20micro-sized%20ZnO%20particles%20in%20human%20lung%20epithelial%20cells&author=W%20Lin&author=Y%20Xu&author=CC%20Huang&volume=11&publication_year=2009&pages=25-39&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R43"> <span class="label">43.</span><cite>Jeng HA, Swanson J. Toxicity of metal oxide nanoparticles in mammalian cells. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2006;41:2699–711. doi: 10.1080/10934520600966177.</cite> [<a href="https://doi.org/10.1080/10934520600966177" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17114101/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Environ%20Sci%20Health%20A%20Tox%20Hazard%20Subst%20Environ%20Eng&title=Toxicity%20of%20metal%20oxide%20nanoparticles%20in%20mammalian%20cells&author=HA%20Jeng&author=J%20Swanson&volume=41&publication_year=2006&pages=2699-711&pmid=17114101&doi=10.1080/10934520600966177&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R44"> <span class="label">44.</span><cite>Mortimer M, Kasemets K, Kahru A. Toxicity of ZnO and CuO nanoparticles to ciliated protozoa Tetrahymena thermophila. Toxicology. 2010;269:182–9. doi: 10.1016/j.tox.2009.07.007.</cite> [<a href="https://doi.org/10.1016/j.tox.2009.07.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19622384/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicology&title=Toxicity%20of%20ZnO%20and%20CuO%20nanoparticles%20to%20ciliated%20protozoa%20Tetrahymena%20thermophila&author=M%20Mortimer&author=K%20Kasemets&author=A%20Kahru&volume=269&publication_year=2010&pages=182-9&pmid=19622384&doi=10.1016/j.tox.2009.07.007&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R45"> <span class="label">45.</span><cite>Franklin NM, Rogers NJ, Apte SC, et al. Comparative toxicity of nanoparticulate ZnO, bulk ZnO, and ZnCl2 to a freshwater microalga (Pseudokirchneriella subcapitata): the importance of particle solubility. Environ Sci Technol. 2007;41:8484–90. doi: 10.1021/es071445r.</cite> [<a href="https://doi.org/10.1021/es071445r" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18200883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Environ%20Sci%20Technol&title=Comparative%20toxicity%20of%20nanoparticulate%20ZnO,%20bulk%20ZnO,%20and%20ZnCl2%20to%20a%20freshwater%20microalga%20(Pseudokirchneriella%20subcapitata):%20the%20importance%20of%20particle%20solubility&author=NM%20Franklin&author=NJ%20Rogers&author=SC%20Apte&volume=41&publication_year=2007&pages=8484-90&pmid=18200883&doi=10.1021/es071445r&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R46"> <span class="label">46.</span><cite>Kasemets K, Ivask A, Dubourguier HC, Kahru A. Toxicity of nanoparticles of ZnO, CuO and TiO2 to yeast Saccharomyces cerevisiae. Toxicol In Vitro. 2009;23:1116–22. doi: 10.1016/j.tiv.2009.05.015.</cite> [<a href="https://doi.org/10.1016/j.tiv.2009.05.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19486936/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol%20In%20Vitro&title=Toxicity%20of%20nanoparticles%20of%20ZnO,%20CuO%20and%20TiO2%20to%20yeast%20Saccharomyces%20cerevisiae&author=K%20Kasemets&author=A%20Ivask&author=HC%20Dubourguier&author=A%20Kahru&volume=23&publication_year=2009&pages=1116-22&pmid=19486936&doi=10.1016/j.tiv.2009.05.015&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R47"> <span class="label">47.</span><cite>Zhu X, Zhu L, Duan Z, et al. Comparative toxicity of several metal oxide nanoparticle aqueous suspensions to Zebrafish (Danio rerio) early developmental stage. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2008;43:278–84. doi: 10.1080/10934520701792779.</cite> [<a href="https://doi.org/10.1080/10934520701792779" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18205059/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Environ%20Sci%20Health%20A%20Tox%20Hazard%20Subst%20Environ%20Eng&title=Comparative%20toxicity%20of%20several%20metal%20oxide%20nanoparticle%20aqueous%20suspensions%20to%20Zebrafish%20(Danio%20rerio)%20early%20developmental%20stage&author=X%20Zhu&author=L%20Zhu&author=Z%20Duan&volume=43&publication_year=2008&pages=278-84&pmid=18205059&doi=10.1080/10934520701792779&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R48"> <span class="label">48.</span><cite>Deng X, Luan Q, Chen W, et al. Nanosized zinc oxide particles induce neural stem cell apoptosis. Nanotechnology. 2009;20:115101–6. doi: 10.1088/0957-4484/20/11/115101.</cite> [<a href="https://doi.org/10.1088/0957-4484/20/11/115101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19420431/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanotechnology&title=Nanosized%20zinc%20oxide%20particles%20induce%20neural%20stem%20cell%20apoptosis&author=X%20Deng&author=Q%20Luan&author=W%20Chen&volume=20&publication_year=2009&pages=115101-6&pmid=19420431&doi=10.1088/0957-4484/20/11/115101&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R49"> <span class="label">49.</span><cite>Brunner TJ, Wick P, Manser P, et al. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol. 2006;40:4374–81. doi: 10.1021/es052069i.</cite> [<a href="https://doi.org/10.1021/es052069i" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16903273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Environ%20Sci%20Technol&title=In%20vitro%20cytotoxicity%20of%20oxide%20nanoparticles:%20comparison%20to%20asbestos,%20silica,%20and%20the%20effect%20of%20particle%20solubility&author=TJ%20Brunner&author=P%20Wick&author=P%20Manser&volume=40&publication_year=2006&pages=4374-81&pmid=16903273&doi=10.1021/es052069i&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R50"> <span class="label">50.</span><cite>Moos PJ, Chung K, Woessner D, et al. ZnO Particulate Matter Requires Cell Contact for Toxicity in Human Colon Cancer Cells. Chem Res Toxicol. 2010;23:733–9. doi: 10.1021/tx900203v.</cite> [<a href="https://doi.org/10.1021/tx900203v" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20155942/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem%20Res%20Toxicol&title=ZnO%20Particulate%20Matter%20Requires%20Cell%20Contact%20for%20Toxicity%20in%20Human%20Colon%20Cancer%20Cells&author=PJ%20Moos&author=K%20Chung&author=D%20Woessner&volume=23&publication_year=2010&pages=733-9&pmid=20155942&doi=10.1021/tx900203v&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R51"> <span class="label">51.</span><cite>Yang H, Liu C, Yang D, et al. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol. 2009;29:69–78. doi: 10.1002/jat.1385.</cite> [<a href="https://doi.org/10.1002/jat.1385" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18756589/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Appl%20Toxicol&title=Comparative%20study%20of%20cytotoxicity,%20oxidative%20stress%20and%20genotoxicity%20induced%20by%20four%20typical%20nanomaterials:%20the%20role%20of%20particle%20size,%20shape%20and%20composition&author=H%20Yang&author=C%20Liu&author=D%20Yang&volume=29&publication_year=2009&pages=69-78&pmid=18756589&doi=10.1002/jat.1385&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R52"> <span class="label">52.</span><cite>Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 1998;68:447S–63S. doi: 10.1093/ajcn/68.2.447S.</cite> [<a href="https://doi.org/10.1093/ajcn/68.2.447S" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9701160/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Clin%20Nutr&title=Zinc%20and%20immune%20function:%20the%20biological%20basis%20of%20altered%20resistance%20to%20infection&author=AH%20Shankar&author=AS%20Prasad&volume=68&publication_year=1998&pages=447S-63S&pmid=9701160&doi=10.1093/ajcn/68.2.447S&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R53"> <span class="label">53.</span><cite>Truong-Tran AQ, Carter J, Ruffin R, Zalewski PD. New insights into the role of zinc in the respiratory epithelium. Immunol Cell Biol. 2001;79:170–7. doi: 10.1046/j.1440-1711.2001.00986.x.</cite> [<a href="https://doi.org/10.1046/j.1440-1711.2001.00986.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11264713/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunol%20Cell%20Biol&title=New%20insights%20into%20the%20role%20of%20zinc%20in%20the%20respiratory%20epithelium&author=AQ%20Truong-Tran&author=J%20Carter&author=R%20Ruffin&author=PD%20Zalewski&volume=79&publication_year=2001&pages=170-7&pmid=11264713&doi=10.1046/j.1440-1711.2001.00986.x&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R54"> <span class="label">54.</span><cite>Lim NC, Freake HC, Bruckner C. Illuminating zinc in biological systems. Chemistry. 2004;11:38–49. doi: 10.1002/chem.200400599.</cite> [<a href="https://doi.org/10.1002/chem.200400599" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15484196/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chemistry&title=Illuminating%20zinc%20in%20biological%20systems&author=NC%20Lim&author=HC%20Freake&author=C%20Bruckner&volume=11&publication_year=2004&pages=38-49&pmid=15484196&doi=10.1002/chem.200400599&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R55"> <span class="label">55.</span><cite>Choi DW, Koh JY. Zinc and brain injury. Annu Rev Neurosci. 1998;21:347–75. doi: 10.1146/annurev.neuro.21.1.347.</cite> [<a href="https://doi.org/10.1146/annurev.neuro.21.1.347" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9530500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu%20Rev%20Neurosci&title=Zinc%20and%20brain%20injury&author=DW%20Choi&author=JY%20Koh&volume=21&publication_year=1998&pages=347-75&pmid=9530500&doi=10.1146/annurev.neuro.21.1.347&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R56"> <span class="label">56.</span><cite>Brasseur F, Couvreur P, Kante B, et al. Actinomycin D absorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor. Eur J Cancer. 1980;16:1441–5. doi: 10.1016/0014-2964(80)90053-5.</cite> [<a href="https://doi.org/10.1016/0014-2964(80)90053-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7227421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Cancer&title=Actinomycin%20D%20absorbed%20on%20polymethylcyanoacrylate%20nanoparticles:%20increased%20efficiency%20against%20an%20experimental%20tumor&author=F%20Brasseur&author=P%20Couvreur&author=B%20Kante&volume=16&publication_year=1980&pages=1441-5&pmid=7227421&doi=10.1016/0014-2964(80)90053-5&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R57"> <span class="label">57.</span><cite>Gregoriadis G, Neerunjun ED. Treatment of tumour bearing mice with liposome-entrapped actinomycin D prolongs their survival. Res Commun Chem Pathol Pharmacol. 1975;10:351–62.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1153840/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Res%20Commun%20Chem%20Pathol%20Pharmacol&title=Treatment%20of%20tumour%20bearing%20mice%20with%20liposome-entrapped%20actinomycin%20D%20prolongs%20their%20survival&author=G%20Gregoriadis&author=ED%20Neerunjun&volume=10&publication_year=1975&pages=351-62&pmid=1153840&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R58"> <span class="label">58.</span><cite>Mohamed F, van der Walle CF. Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J Pharm Sci. 2008;97:71–87. doi: 10.1002/jps.21082.</cite> [<a href="https://doi.org/10.1002/jps.21082" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17722085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pharm%20Sci&title=Engineering%20biodegradable%20polyester%20particles%20with%20specific%20drug%20targeting%20and%20drug%20release%20properties&author=F%20Mohamed&author=CF%20van%20der%20Walle&volume=97&publication_year=2008&pages=71-87&pmid=17722085&doi=10.1002/jps.21082&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R59"> <span class="label">59.</span><cite>Hillebrenner H, Buyukserin F, Kang M, et al. Corking nano test tubes by chemical self-assembly. J Am Chem Soc. 2006;128:4236–7. doi: 10.1021/ja058455h.</cite> [<a href="https://doi.org/10.1021/ja058455h" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16568992/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Chem%20Soc&title=Corking%20nano%20test%20tubes%20by%20chemical%20self-assembly&author=H%20Hillebrenner&author=F%20Buyukserin&author=M%20Kang&volume=128&publication_year=2006&pages=4236-7&pmid=16568992&doi=10.1021/ja058455h&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R60"> <span class="label">60.</span><cite>Schillemans JP, van Nostrum CF. Molecularly imprinted polymer particles: synthetic receptors for future medicine. Nanomed. 2006;1:437–47. doi: 10.2217/17435889.1.4.437.</cite> [<a href="https://doi.org/10.2217/17435889.1.4.437" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17716146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomed&title=Molecularly%20imprinted%20polymer%20particles:%20synthetic%20receptors%20for%20future%20medicine&author=JP%20Schillemans&author=CF%20van%20Nostrum&volume=1&publication_year=2006&pages=437-47&pmid=17716146&doi=10.2217/17435889.1.4.437&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R61"> <span class="label">61.</span><cite>Batist G, Barton J, Chaikin P, et al. Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy. Expert Opin Pharmacother. 2002;3:1739–51. doi: 10.1517/14656566.3.12.1739.</cite> [<a href="https://doi.org/10.1517/14656566.3.12.1739" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12472371/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Pharmacother&title=Myocet%20(liposome-encapsulated%20doxorubicin%20citrate):%20a%20new%20approach%20in%20breast%20cancer%20therapy&author=G%20Batist&author=J%20Barton&author=P%20Chaikin&volume=3&publication_year=2002&pages=1739-51&pmid=12472371&doi=10.1517/14656566.3.12.1739&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R62"> <span class="label">62.</span><cite>Cai R, Hashimoto K, Itoh Y, et al. Photokilling of malignant cells with ultrafine titanium dioxide powder. Bulletin Chemical Society Japan. 1991;64:1268–73.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Bulletin%20Chemical%20Society%20Japan&title=Photokilling%20of%20malignant%20cells%20with%20ultrafine%20titanium%20dioxide%20powder&author=R%20Cai&author=K%20Hashimoto&author=Y%20Itoh&volume=64&publication_year=1991&pages=1268-73&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R63"> <span class="label">63.</span><cite>Cai R, Kubota Y, Shuin T, et al. Induction of cytotoxicity by photoexcited TiO2 particles. Cancer Res. 1992;52:2346–8.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1559237/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&title=Induction%20of%20cytotoxicity%20by%20photoexcited%20TiO2%20particles&author=R%20Cai&author=Y%20Kubota&author=T%20Shuin&volume=52&publication_year=1992&pages=2346-8&pmid=1559237&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R64"> <span class="label">64.</span><cite>Bakalova R, Ohba H, Zhelev Z, et al. Quantum dots as photosensitizers? Nat Biotechnol. 2004;22:1360–1. doi: 10.1038/nbt1104-1360.</cite> [<a href="https://doi.org/10.1038/nbt1104-1360" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15529155/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Biotechnol&title=Quantum%20dots%20as%20photosensitizers?&author=R%20Bakalova&author=H%20Ohba&author=Z%20Zhelev&volume=22&publication_year=2004&pages=1360-1&pmid=15529155&doi=10.1038/nbt1104-1360&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R65"> <span class="label">65.</span><cite>Jordan A, Scholz R, Maier-Hauff K, et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol. 2006;78:7–14. doi: 10.1007/s11060-005-9059-z.</cite> [<a href="https://doi.org/10.1007/s11060-005-9059-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16314937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurooncol&title=The%20effect%20of%20thermotherapy%20using%20magnetic%20nanoparticles%20on%20rat%20malignant%20glioma&author=A%20Jordan&author=R%20Scholz&author=K%20Maier-Hauff&volume=78&publication_year=2006&pages=7-14&pmid=16314937&doi=10.1007/s11060-005-9059-z&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R66"> <span class="label">66.</span><cite>Jordan A, Scholz R, Wust P, et al. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magnetism Magnetic Materials. 1999;201:413–9.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Magnetism%20Magnetic%20Materials&title=Magnetic%20fluid%20hyperthermia%20(MFH):%20Cancer%20treatment%20with%20AC%20magnetic%20field%20induced%20excitation%20of%20biocompatible%20superparamagnetic%20nanoparticles&author=A%20Jordan&author=R%20Scholz&author=P%20Wust&volume=201&publication_year=1999&pages=413-9&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R67"> <span class="label">67•.</span><cite>Nohynek GJ, Lademann J, Ribaud C, Roberts MS. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol. 2007;37:251–77. doi: 10.1080/10408440601177780. Study on the use and safety of nanoparticles in cosmetic products.</cite> [<a href="https://doi.org/10.1080/10408440601177780" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17453934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Rev%20Toxicol&title=Grey%20goo%20on%20the%20skin?%20Nanotechnology,%20cosmetic%20and%20sunscreen%20safety&author=GJ%20Nohynek&author=J%20Lademann&author=C%20Ribaud&author=MS%20Roberts&volume=37&publication_year=2007&pages=251-77&pmid=17453934&doi=10.1080/10408440601177780&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R68"> <span class="label">68.</span><cite>Applerot G, Lipovsky A, Dror R, et al. Enhanced antibacterial activity of nanocrystalline ZnO due to increased ROS-mediated cell injury. Advanced Functional Materials. 2009;19:842–52.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Advanced%20Functional%20Materials&title=Enhanced%20antibacterial%20activity%20of%20nanocrystalline%20ZnO%20due%20to%20increased%20ROS-mediated%20cell%20injury&author=G%20Applerot&author=A%20Lipovsky&author=R%20Dror&volume=19&publication_year=2009&pages=842-52&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R69"> <span class="label">69.</span><cite>Colon G, Ward BC, Webster TJ. Increased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2. J Biomed Mater Res A. 2006;78:595–604. doi: 10.1002/jbm.a.30789.</cite> [<a href="https://doi.org/10.1002/jbm.a.30789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16752397/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biomed%20Mater%20Res%20A&title=Increased%20osteoblast%20and%20decreased%20Staphylococcus%20epidermidis%20functions%20on%20nanophase%20ZnO%20and%20TiO2&author=G%20Colon&author=BC%20Ward&author=TJ%20Webster&volume=78&publication_year=2006&pages=595-604&pmid=16752397&doi=10.1002/jbm.a.30789&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R70"> <span class="label">70.</span><cite>Dhobale S, Thite T, Laware SL, et al. Zinc oxide nanoparticles as novel alpha-amylase inhibitors. J Applied Phys. 2008;104:0949071–5.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Applied%20Phys&title=Zinc%20oxide%20nanoparticles%20as%20novel%20alpha-amylase%20inhibitors&author=S%20Dhobale&author=T%20Thite&author=SL%20Laware&volume=104&publication_year=2008&pages=0949071-5&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R71"> <span class="label">71.</span><cite>Yamaki K, Yoshino S. Comparison of inhibitory activities of zinc oxide ultrafine and fine particulates on IgE-induced mast cell activation. Biometals. 2009;22:1031–40. doi: 10.1007/s10534-009-9254-z.</cite> [<a href="https://doi.org/10.1007/s10534-009-9254-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19609684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biometals&title=Comparison%20of%20inhibitory%20activities%20of%20zinc%20oxide%20ultrafine%20and%20fine%20particulates%20on%20IgE-induced%20mast%20cell%20activation&author=K%20Yamaki&author=S%20Yoshino&volume=22&publication_year=2009&pages=1031-40&pmid=19609684&doi=10.1007/s10534-009-9254-z&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R72"> <span class="label">72.</span><cite>Zhou J, Xu N, Wang ZL. Dissolving behavior and stability of Zno wires in biofluids: A study on biodegradability and biocompatibility. Advanced Materials. 2006;18:2432–35.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Advanced%20Materials&title=Dissolving%20behavior%20and%20stability%20of%20Zno%20wires%20in%20biofluids:%20A%20study%20on%20biodegradability%20and%20biocompatibility&author=J%20Zhou&author=N%20Xu&author=ZL%20Wang&volume=18&publication_year=2006&pages=2432-35&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R73"> <span class="label">73.</span><cite>Hanley C, Thurber A, Hanna C, et al. The influences of cell type and ZnO nanoparticle size and immune cell cytotoxicity and cytokine induction. Nanoscale Res Lett. 2009;4:1409–20. doi: 10.1007/s11671-009-9413-8.</cite> [<a href="https://doi.org/10.1007/s11671-009-9413-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2894345/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20652105/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale%20Res%20Lett&title=The%20influences%20of%20cell%20type%20and%20ZnO%20nanoparticle%20size%20and%20immune%20cell%20cytotoxicity%20and%20cytokine%20induction&author=C%20Hanley&author=A%20Thurber&author=C%20Hanna&volume=4&publication_year=2009&pages=1409-20&pmid=20652105&doi=10.1007/s11671-009-9413-8&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R74"> <span class="label">74.</span><cite>Qu F, Morais PC. Energy levels in metal oxide semiconductor quantum dots in water-based colloids. J of Chem Physics. 1999;111:8588–94.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J%20of%20Chem%20Physics&title=Energy%20levels%20in%20metal%20oxide%20semiconductor%20quantum%20dots%20in%20water-based%20colloids&author=F%20Qu&author=PC%20Morais&volume=111&publication_year=1999&pages=8588-94&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R75"> <span class="label">75.</span><cite>Qu F, Morais PC. The pH dependence of the surface charge density in oxide-based semiconductor nanoparticles immersed in aqueous solution. IEEE Transactions on Magnetics. 2001;37:2654–6.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=IEEE%20Transactions%20on%20Magnetics&title=The%20pH%20dependence%20of%20the%20surface%20charge%20density%20in%20oxide-based%20semiconductor%20nanoparticles%20immersed%20in%20aqueous%20solution&author=F%20Qu&author=PC%20Morais&volume=37&publication_year=2001&pages=2654-6&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R76"> <span class="label">76.</span><cite>Degen A, Kosec M. Effect of pH and impurities on the surface charge of zinc oxide in aqueous solution. J Europena Ceramic Society. 2000;20:667–73.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Europena%20Ceramic%20Society&title=Effect%20of%20pH%20and%20impurities%20on%20the%20surface%20charge%20of%20zinc%20oxide%20in%20aqueous%20solution&author=A%20Degen&author=M%20Kosec&volume=20&publication_year=2000&pages=667-73&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R77"> <span class="label">77.</span><cite>Nagao M. Physiosorption of water on zinc oxide surface. J Phys Chem. 1971;75:3822–8.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Phys%20Chem&title=Physiosorption%20of%20water%20on%20zinc%20oxide%20surface&author=M%20Nagao&volume=75&publication_year=1971&pages=3822-8&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R78"> <span class="label">78.</span><cite>Grabarek Z, Gergely J. Zero-length crosslinking procedure with the use of active esters. Anal Biochem. 1990;185:131–5. doi: 10.1016/0003-2697(90)90267-d.</cite> [<a href="https://doi.org/10.1016/0003-2697(90)90267-d" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2344038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anal%20Biochem&title=Zero-length%20crosslinking%20procedure%20with%20the%20use%20of%20active%20esters&author=Z%20Grabarek&author=J%20Gergely&volume=185&publication_year=1990&pages=131-5&pmid=2344038&doi=10.1016/0003-2697(90)90267-d&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R79"> <span class="label">79.</span><cite>Horie M, Nishio K, Fujita K, et al. Protein adsorption of ultrafine metal oxide and its influence on cytotoxicity toward cultured cells. Chem Res Toxicol. 2009;22:543–53. doi: 10.1021/tx800289z.</cite> [<a href="https://doi.org/10.1021/tx800289z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19216582/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem%20Res%20Toxicol&title=Protein%20adsorption%20of%20ultrafine%20metal%20oxide%20and%20its%20influence%20on%20cytotoxicity%20toward%20cultured%20cells&author=M%20Horie&author=K%20Nishio&author=K%20Fujita&volume=22&publication_year=2009&pages=543-53&pmid=19216582&doi=10.1021/tx800289z&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R80"> <span class="label">80.</span><cite>Gorelikov I, Matsuura N. Single-step coating of mesoporous silica on cetyltrimethyl ammonium bromide-capped nanoparticles. Nano Letters. 2008;8:369–73. doi: 10.1021/nl0727415.</cite> [<a href="https://doi.org/10.1021/nl0727415" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18072800/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20Letters&title=Single-step%20coating%20of%20mesoporous%20silica%20on%20cetyltrimethyl%20ammonium%20bromide-capped%20nanoparticles&author=I%20Gorelikov&author=N%20Matsuura&volume=8&publication_year=2008&pages=369-73&pmid=18072800&doi=10.1021/nl0727415&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R81"> <span class="label">81.</span><cite>Brayner R, Ferrari-Iliou R, Brivois N, et al. Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett. 2006;6:866–70. doi: 10.1021/nl052326h.</cite> [<a href="https://doi.org/10.1021/nl052326h" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16608300/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20Lett&title=Toxicological%20impact%20studies%20based%20on%20Escherichia%20coli%20bacteria%20in%20ultrafine%20ZnO%20nanoparticles%20colloidal%20medium&author=R%20Brayner&author=R%20Ferrari-Iliou&author=N%20Brivois&volume=6&publication_year=2006&pages=866-70&pmid=16608300&doi=10.1021/nl052326h&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R82"> <span class="label">82.</span><cite>Long TC, Saleh N, Tilton RD, et al. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ Sci Technol. 2006;40:4346–52. doi: 10.1021/es060589n.</cite> [<a href="https://doi.org/10.1021/es060589n" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16903269/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Environ%20Sci%20Technol&title=Titanium%20dioxide%20(P25)%20produces%20reactive%20oxygen%20species%20in%20immortalized%20brain%20microglia%20(BV2):%20implications%20for%20nanoparticle%20neurotoxicity&author=TC%20Long&author=N%20Saleh&author=RD%20Tilton&volume=40&publication_year=2006&pages=4346-52&pmid=16903269&doi=10.1021/es060589n&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R83"> <span class="label">83.</span><cite>Lovric J, Cho SJ, Winnik FM, Maysinger D. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem Biol. 2005;12:1227–34. doi: 10.1016/j.chembiol.2005.09.008.</cite> [<a href="https://doi.org/10.1016/j.chembiol.2005.09.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16298302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem%20Biol&title=Unmodified%20cadmium%20telluride%20quantum%20dots%20induce%20reactive%20oxygen%20species%20formation%20leading%20to%20multiple%20organelle%20damage%20and%20cell%20death&author=J%20Lovric&author=SJ%20Cho&author=FM%20Winnik&author=D%20Maysinger&volume=12&publication_year=2005&pages=1227-34&pmid=16298302&doi=10.1016/j.chembiol.2005.09.008&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R84"> <span class="label">84.</span><cite>Lewinski N, Colvin V, Drezek R. Cytotoxicity of nanoparticles. Small. 2008;4:26–49. doi: 10.1002/smll.200700595.</cite> [<a href="https://doi.org/10.1002/smll.200700595" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18165959/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Small&title=Cytotoxicity%20of%20nanoparticles&author=N%20Lewinski&author=V%20Colvin&author=R%20Drezek&volume=4&publication_year=2008&pages=26-49&pmid=18165959&doi=10.1002/smll.200700595&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R85"> <span class="label">85.</span><cite>Lany S, Osorio-Guillen J, Zunger A. Origins of the doping asymmetry in oxides: Hole doping in NiO versus electron doping in ZnO. Physical Review B. 2007;75:2412031–4.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Physical%20Review%20B&title=Origins%20of%20the%20doping%20asymmetry%20in%20oxides:%20Hole%20doping%20in%20NiO%20versus%20electron%20doping%20in%20ZnO&author=S%20Lany&author=J%20Osorio-Guillen&author=A%20Zunger&volume=75&publication_year=2007&pages=2412031-4&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R86"> <span class="label">86.</span><cite>Sharma SK, Pujari PK, Sudarshan K, et al. Positron annihilation studies in ZnO nanoparticles. Solid State Communications. 2009;149:550–4.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Solid%20State%20Communications&title=Positron%20annihilation%20studies%20in%20ZnO%20nanoparticles&author=SK%20Sharma&author=PK%20Pujari&author=K%20Sudarshan&volume=149&publication_year=2009&pages=550-4&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R87"> <span class="label">87.</span><cite>Salem IA. Catalytic decomposition of hydrogen peroxide over supported ZnO. Monatshefte fur Chemie. 2000;131:1139–50.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Monatshefte%20fur%20Chemie&title=Catalytic%20decomposition%20of%20hydrogen%20peroxide%20over%20supported%20ZnO&author=IA%20Salem&volume=131&publication_year=2000&pages=1139-50&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R88"> <span class="label">88.</span><cite>Padmavathy N, Vijayaraghavan R. Enhanced bioactivity of ZnO nanoparticles - an antimicrobial study. Sci Technol Adv Mater. 2008;9:1–7. doi: 10.1088/1468-6996/9/3/035004.</cite> [<a href="https://doi.org/10.1088/1468-6996/9/3/035004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5099658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27878001/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Technol%20Adv%20Mater&title=Enhanced%20bioactivity%20of%20ZnO%20nanoparticles%20-%20an%20antimicrobial%20study&author=N%20Padmavathy&author=R%20Vijayaraghavan&volume=9&publication_year=2008&pages=1-7&pmid=27878001&doi=10.1088/1468-6996/9/3/035004&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R89"> <span class="label">89.</span><cite>Matsunaga T, Tomoda R, Nakajima T, Wake H. Photoelectrochemical sterilization of microbial cells by semiconductor powders. FEMS Microbiology Letters. 1985;29:211–4.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=FEMS%20Microbiology%20Letters&title=Photoelectrochemical%20sterilization%20of%20microbial%20cells%20by%20semiconductor%20powders&author=T%20Matsunaga&author=R%20Tomoda&author=T%20Nakajima&author=H%20Wake&volume=29&publication_year=1985&pages=211-4&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R90"> <span class="label">90.</span><cite>Kamat PV, Meisel D. Nanoscience opportunities in environmental remediation. C R Chimie. 2003;6:999–1007.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=C%20R%20Chimie&title=Nanoscience%20opportunities%20in%20environmental%20remediation&author=PV%20Kamat&author=D%20Meisel&volume=6&publication_year=2003&pages=999-1007&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R91"> <span class="label">91.</span><cite>Hoffman AJ, Carraway ER, Hoffman M. Photocatalytic production of hydrogen peroxide and organic peroxides on quantum-sized semiconductor colloids. Environmental Science and Technology. 1994;28:776–85. doi: 10.1021/es00054a006.</cite> [<a href="https://doi.org/10.1021/es00054a006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22191816/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Environmental%20Science%20and%20Technology&title=Photocatalytic%20production%20of%20hydrogen%20peroxide%20and%20organic%20peroxides%20on%20quantum-sized%20semiconductor%20colloids&author=AJ%20Hoffman&author=ER%20Carraway&author=M%20Hoffman&volume=28&publication_year=1994&pages=776-85&pmid=22191816&doi=10.1021/es00054a006&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R92"> <span class="label">92.</span><cite>Hays J, Reddy KM, Graces N, et al. Effect of Co doping on the structural, optical and magnetic properties of ZnO. J Phys Condens Matter. 2007;19:226203–26. doi: 10.1088/0953-8984/19/26/266203.</cite> [<a href="https://doi.org/10.1088/0953-8984/19/26/266203" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21694080/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Phys%20Condens%20Matter&title=Effect%20of%20Co%20doping%20on%20the%20structural,%20optical%20and%20magnetic%20properties%20of%20ZnO&author=J%20Hays&author=KM%20Reddy&author=N%20Graces&volume=19&publication_year=2007&pages=226203-26&pmid=21694080&doi=10.1088/0953-8984/19/26/266203&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R93"> <span class="label">93.</span><cite>Sun L, Rippon JA, Cookson PG, et al. Effects of undoped and manganese-doped zinc oxide nanoparticles on the colour fading of dyed polyester fabrics. Chemical Engineering Journal. 2009;147:391–8.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Chemical%20Engineering%20Journal&title=Effects%20of%20undoped%20and%20manganese-doped%20zinc%20oxide%20nanoparticles%20on%20the%20colour%20fading%20of%20dyed%20polyester%20fabrics&author=L%20Sun&author=JA%20Rippon&author=PG%20Cookson&volume=147&publication_year=2009&pages=391-8&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R94"> <span class="label">94.</span><cite>Pirkanniemi KAMS. Heterogeneous water phase catalysis as an environmental application: a review. Chemosphere. 2002;48:1047–60. doi: 10.1016/s0045-6535(02)00168-6.</cite> [<a href="https://doi.org/10.1016/s0045-6535(02)00168-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12227510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chemosphere&title=Heterogeneous%20water%20phase%20catalysis%20as%20an%20environmental%20application:%20a%20review&author=KAMS%20Pirkanniemi&volume=48&publication_year=2002&pages=1047-60&pmid=12227510&doi=10.1016/s0045-6535(02)00168-6&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R95"> <span class="label">95.</span><cite>Choi W, Termin A, Hoffman MR. The role of metal-ion dopants in quantum-sized TiO2. J Phys Chem. 1994;98:13669–79.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Phys%20Chem&title=The%20role%20of%20metal-ion%20dopants%20in%20quantum-sized%20TiO2&author=W%20Choi&author=A%20Termin&author=MR%20Hoffman&volume=98&publication_year=1994&pages=13669-79&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R96"> <span class="label">96.</span><cite>Petit A, Mwale F, Tkaczyk C, et al. Induction of protein oxidation by cobalt and chromium ions in human U937 macrophages. Biomater. 2005;26:4416–22. doi: 10.1016/j.biomaterials.2004.11.019.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2004.11.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15701370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomater&title=Induction%20of%20protein%20oxidation%20by%20cobalt%20and%20chromium%20ions%20in%20human%20U937%20macrophages&author=A%20Petit&author=F%20Mwale&author=C%20Tkaczyk&volume=26&publication_year=2005&pages=4416-22&pmid=15701370&doi=10.1016/j.biomaterials.2004.11.019&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R97"> <span class="label">97.</span><cite>George S, Pokhrel S, Xia T, et al. Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano. 2010;4:15–29. doi: 10.1021/nn901503q.</cite> [<a href="https://doi.org/10.1021/nn901503q" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3900637/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20043640/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&title=Use%20of%20a%20rapid%20cytotoxicity%20screening%20approach%20to%20engineer%20a%20safer%20zinc%20oxide%20nanoparticle%20through%20iron%20doping&author=S%20George&author=S%20Pokhrel&author=T%20Xia&volume=4&publication_year=2010&pages=15-29&pmid=20043640&doi=10.1021/nn901503q&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R98"> <span class="label">98.</span><cite>Reddy KM, Feris K, Bell J, et al. Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Applied Physics Letters. 2007;90:213902–3. doi: 10.1063/1.2742324.</cite> [<a href="https://doi.org/10.1063/1.2742324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2153488/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18160973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Applied%20Physics%20Letters&title=Selective%20toxicity%20of%20zinc%20oxide%20nanoparticles%20to%20prokaryotic%20and%20eukaryotic%20systems&author=KM%20Reddy&author=K%20Feris&author=J%20Bell&volume=90&publication_year=2007&pages=213902-3&pmid=18160973&doi=10.1063/1.2742324&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R99"> <span class="label">99•.</span><cite>Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009;3:16–20. doi: 10.1021/nn900002m. Murine study showing efficiency of nanoparticle-conjugates in reducing tumor progression in vivo.</cite> [<a href="https://doi.org/10.1021/nn900002m" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19206243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Nano&title=Impact%20of%20nanotechnology%20on%20drug%20delivery&author=OC%20Farokhzad&author=R%20Langer&volume=3&publication_year=2009&pages=16-20&pmid=19206243&doi=10.1021/nn900002m&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R100"> <span class="label">100.</span><cite>Yuan Q, Hein S, Misra RD. New generation of chitosan-encapsulated ZnO quantum dots loaded with drug: Synthesis, characterization and in vitro drug delivery response. Acta Biomater. 2010;6:2732–9. doi: 10.1016/j.actbio.2010.01.025.</cite> [<a href="https://doi.org/10.1016/j.actbio.2010.01.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20100604/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Biomater&title=New%20generation%20of%20chitosan-encapsulated%20ZnO%20quantum%20dots%20loaded%20with%20drug:%20Synthesis,%20characterization%20and%20in%20vitro%20drug%20delivery%20response&author=Q%20Yuan&author=S%20Hein&author=RD%20Misra&volume=6&publication_year=2010&pages=2732-9&pmid=20100604&doi=10.1016/j.actbio.2010.01.025&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R101"> <span class="label">101.</span><cite>Jain TK, Morales MA, Sahoo SK, et al. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm. 2005;2:194–205. doi: 10.1021/mp0500014.</cite> [<a href="https://doi.org/10.1021/mp0500014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15934780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Pharm&title=Iron%20oxide%20nanoparticles%20for%20sustained%20delivery%20of%20anticancer%20agents&author=TK%20Jain&author=MA%20Morales&author=SK%20Sahoo&volume=2&publication_year=2005&pages=194-205&pmid=15934780&doi=10.1021/mp0500014&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R102"> <span class="label">102.</span><cite>Sun C, Fang C, Stepherr Z, et al. Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles. Future Medicine. 2008;3:495–505. doi: 10.2217/17435889.3.4.495.</cite> [<a href="https://doi.org/10.2217/17435889.3.4.495" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2890026/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18694312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Future%20Medicine&title=Tumor-targeted%20drug%20delivery%20and%20MRI%20contrast%20enhancement%20by%20chlorotoxin-conjugated%20iron%20oxide%20nanoparticles&author=C%20Sun&author=C%20Fang&author=Z%20Stepherr&volume=3&publication_year=2008&pages=495-505&pmid=18694312&doi=10.2217/17435889.3.4.495&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R103"> <span class="label">103.</span><cite>Patil S, Reshetnikov S, Haldar MK, et al. Surface-derivatized nanoceria with human carbonic anhydrase II inhibitors and fluorophores: a potential drug delivery device. J Phys Chem C. 2007;111:8437–42.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Phys%20Chem%20C&title=Surface-derivatized%20nanoceria%20with%20human%20carbonic%20anhydrase%20II%20inhibitors%20and%20fluorophores:%20a%20potential%20drug%20delivery%20device&author=S%20Patil&author=S%20Reshetnikov&author=MK%20Haldar&volume=111&publication_year=2007&pages=8437-42&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R104"> <span class="label">104.</span><cite>Shen W, Xiong H, Xu Y, et al. ZnO-poly(methyl methacrylate) nanobeads for enriching and desalting low-abundant proteins followed by directly MALDI-TOF MS analysis. Anal Chem. 2008;80:6758–63. doi: 10.1021/ac801001b.</cite> [<a href="https://doi.org/10.1021/ac801001b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18681459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anal%20Chem&title=ZnO-poly(methyl%20methacrylate)%20nanobeads%20for%20enriching%20and%20desalting%20low-abundant%20proteins%20followed%20by%20directly%20MALDI-TOF%20MS%20analysis&author=W%20Shen&author=H%20Xiong&author=Y%20Xu&volume=80&publication_year=2008&pages=6758-63&pmid=18681459&doi=10.1021/ac801001b&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R105"> <span class="label">105.</span><cite>Dorfman A, Parajuli O, Kumar N, Hahm JI. Novel telomeric repeat elongation assay performed on zinc oxide nanorod array supports. J Nanosci Nanotechnol. 2008;8:410–5. doi: 10.1166/jnn.2008.146.</cite> [<a href="https://doi.org/10.1166/jnn.2008.146" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18468092/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Nanosci%20Nanotechnol&title=Novel%20telomeric%20repeat%20elongation%20assay%20performed%20on%20zinc%20oxide%20nanorod%20array%20supports&author=A%20Dorfman&author=O%20Parajuli&author=N%20Kumar&author=JI%20Hahm&volume=8&publication_year=2008&pages=410-5&pmid=18468092&doi=10.1166/jnn.2008.146&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R106"> <span class="label">106.</span><cite>Lee H, Lee E, Kim do K, et al. Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J Am Chem Soc. 2006;128:7383–9. doi: 10.1021/ja061529k.</cite> [<a href="https://doi.org/10.1021/ja061529k" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16734494/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Chem%20Soc&title=Antibiofouling%20polymer-coated%20superparamagnetic%20iron%20oxide%20nanoparticles%20as%20potential%20magnetic%20resonance%20contrast%20agents%20for%20in%20vivo%20cancer%20imaging&author=H%20Lee&author=E%20Lee&author=K%20Kim%20do&volume=128&publication_year=2006&pages=7383-9&pmid=16734494&doi=10.1021/ja061529k&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R107"> <span class="label">107.</span><cite>Jain TK, Richey J, Strand M, et al. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomater. 2008;29:4012–21. doi: 10.1016/j.biomaterials.2008.07.004.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2008.07.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2593647/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18649936/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomater&title=Magnetic%20nanoparticles%20with%20dual%20functional%20properties:%20drug%20delivery%20and%20magnetic%20resonance%20imaging&author=TK%20Jain&author=J%20Richey&author=M%20Strand&volume=29&publication_year=2008&pages=4012-21&pmid=18649936&doi=10.1016/j.biomaterials.2008.07.004&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R108"> <span class="label">108.</span><cite>Li Z, Xiang J, Zhang W, et al. Nanoparticle delivery of anti-metastatic NM23-H1 gene improves chemotherapy in a mouse tumor model. Cancer Gene Ther. 2009;16:423–9. doi: 10.1038/cgt.2008.97.</cite> [<a href="https://doi.org/10.1038/cgt.2008.97" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19096443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Gene%20Ther&title=Nanoparticle%20delivery%20of%20anti-metastatic%20NM23-H1%20gene%20improves%20chemotherapy%20in%20a%20mouse%20tumor%20model&author=Z%20Li&author=J%20Xiang&author=W%20Zhang&volume=16&publication_year=2009&pages=423-9&pmid=19096443&doi=10.1038/cgt.2008.97&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R109"> <span class="label">109.</span><cite>Nie L, Gao L, Yan X, Wang T. Functionalized tetrapod-like ZnO nanostructures for plasmid DNA purification, polymerase chain reaction and delivery. Nanotechnology. 2007;18:015101–7.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Nanotechnology&title=Functionalized%20tetrapod-like%20ZnO%20nanostructures%20for%20plasmid%20DNA%20purification,%20polymerase%20chain%20reaction%20and%20delivery&author=L%20Nie&author=L%20Gao&author=X%20Yan&author=T%20Wang&volume=18&publication_year=2007&pages=015101-7&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R110"> <span class="label">110.</span><cite>Zhang P, Liu W. ZnO QD@PMAA-co-PDMAEMA nonviral vector for plasmid DNA delivery and bioimaging. Biomater. 2010;31:3087–94. doi: 10.1016/j.biomaterials.2010.01.007.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2010.01.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20096454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomater&title=ZnO%20QD@PMAA-co-PDMAEMA%20nonviral%20vector%20for%20plasmid%20DNA%20delivery%20and%20bioimaging&author=P%20Zhang&author=W%20Liu&volume=31&publication_year=2010&pages=3087-94&pmid=20096454&doi=10.1016/j.biomaterials.2010.01.007&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R111"> <span class="label">111.</span><cite>Gojova A, Guo B, Kota RS, et al. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ Health Perspect. 2007;115:403–9. doi: 10.1289/ehp.8497.</cite> [<a href="https://doi.org/10.1289/ehp.8497" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1849911/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17431490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Environ%20Health%20Perspect&title=Induction%20of%20inflammation%20in%20vascular%20endothelial%20cells%20by%20metal%20oxide%20nanoparticles:%20effect%20of%20particle%20composition&author=A%20Gojova&author=B%20Guo&author=RS%20Kota&volume=115&publication_year=2007&pages=403-9&pmid=17431490&doi=10.1289/ehp.8497&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R112"> <span class="label">112.</span><cite>Beyerle A, Schulz H, Kissel T, Stoeger T. Screening strategy to avoid toxicological hazards of inhaled nanoparticles for drug delivery: the use of alpha-quartz and nano zinc oxide particles as benchmark. Inhaled Particles. 2009;151:1–9.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Inhaled%20Particles&title=Screening%20strategy%20to%20avoid%20toxicological%20hazards%20of%20inhaled%20nanoparticles%20for%20drug%20delivery:%20the%20use%20of%20alpha-quartz%20and%20nano%20zinc%20oxide%20particles%20as%20benchmark&author=A%20Beyerle&author=H%20Schulz&author=T%20Kissel&author=T%20Stoeger&volume=151&publication_year=2009&pages=1-9&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R113"> <span class="label">113.</span><cite>Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol. 2009;9:271–285. doi: 10.1038/nri2526.</cite> [<a href="https://doi.org/10.1038/nri2526" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2737409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19319144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Immunol&title=The%20role%20of%20TNF%20superfamily%20members%20in%20T-cell%20function%20and%20diseases&author=M%20Croft&volume=9&publication_year=2009&pages=271-285&pmid=19319144&doi=10.1038/nri2526&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R114"> <span class="label">114.</span><cite>Lappin MB, Campbell JD. The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in haematological malignancy. Blood Rev. 2000;14:228–39. doi: 10.1054/blre.2000.0136.</cite> [<a href="https://doi.org/10.1054/blre.2000.0136" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11124110/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood%20Rev&title=The%20Th1-Th2%20classification%20of%20cellular%20immune%20responses:%20concepts,%20current%20thinking%20and%20applications%20in%20haematological%20malignancy&author=MB%20Lappin&author=JD%20Campbell&volume=14&publication_year=2000&pages=228-39&pmid=11124110&doi=10.1054/blre.2000.0136&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R115"> <span class="label">115.</span><cite>Zhang L, Gu FX, Chan JM, et al. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2008;83:761–9. doi: 10.1038/sj.clpt.6100400.</cite> [<a href="https://doi.org/10.1038/sj.clpt.6100400" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17957183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Pharmacol%20Ther&title=Nanoparticles%20in%20medicine:%20therapeutic%20applications%20and%20developments&author=L%20Zhang&author=FX%20Gu&author=JM%20Chan&volume=83&publication_year=2008&pages=761-9&pmid=17957183&doi=10.1038/sj.clpt.6100400&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R116"> <span class="label">116.</span><cite>Kehrer DF, Bos AM, Verweij J, et al. Phase I and pharmacologic study of liposomal lurtotecan, NX 211: urinary excretion predicts hematologic toxicity. J Clin Oncol. 2002;20:1222–31. doi: 10.1200/JCO.2002.20.5.1222.</cite> [<a href="https://doi.org/10.1200/JCO.2002.20.5.1222" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11870164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&title=Phase%20I%20and%20pharmacologic%20study%20of%20liposomal%20lurtotecan,%20NX%20211:%20urinary%20excretion%20predicts%20hematologic%20toxicity&author=DF%20Kehrer&author=AM%20Bos&author=J%20Verweij&volume=20&publication_year=2002&pages=1222-31&pmid=11870164&doi=10.1200/JCO.2002.20.5.1222&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R117"> <span class="label">117.</span><cite>Cicek M, Iwaniec UT, Goblirsch MJ, et al. 2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo. Cancer Res. 2007;67:10106–11. doi: 10.1158/0008-5472.CAN-07-1362.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-07-1362" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17974950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&title=2-Methoxyestradiol%20suppresses%20osteolytic%20breast%20cancer%20tumor%20progression%20in%20vivo&author=M%20Cicek&author=UT%20Iwaniec&author=MJ%20Goblirsch&volume=67&publication_year=2007&pages=10106-11&pmid=17974950&doi=10.1158/0008-5472.CAN-07-1362&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R118"> <span class="label">118.</span><cite>Dragovich T, Mendelson D, Kurtin S, et al. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer. Cancer Chemother Pharmacol. 2006;58:759–764. doi: 10.1007/s00280-006-0235-4.</cite> [<a href="https://doi.org/10.1007/s00280-006-0235-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16847673/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Chemother%20Pharmacol&title=A%20Phase%202%20trial%20of%20the%20liposomal%20DACH%20platinum%20L-NDDP%20in%20patients%20with%20therapy-refractory%20advanced%20colorectal%20cancer&author=T%20Dragovich&author=D%20Mendelson&author=S%20Kurtin&volume=58&publication_year=2006&pages=759-764&pmid=16847673&doi=10.1007/s00280-006-0235-4&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R119"> <span class="label">119.</span><cite>Goel R, Shah N, Visaria R, et al. Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system. Nanomedicine (Lond) 2009;4:401–10. doi: 10.2217/nnm.09.21.</cite> [<a href="https://doi.org/10.2217/nnm.09.21" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2727870/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19505243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine%20(Lond)&title=Biodistribution%20of%20TNF-alpha-coated%20gold%20nanoparticles%20in%20an%20in%20vivo%20model%20system&author=R%20Goel&author=N%20Shah&author=R%20Visaria&volume=4&publication_year=2009&pages=401-10&pmid=19505243&doi=10.2217/nnm.09.21&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R120"> <span class="label">120.</span><cite>Gratton SE, Williams SS, Napier ME, et al. The pursuit of a scalable nanofabrication platform for use in material and life science applications. Acc Chem Res. 2008;41:1685–95. doi: 10.1021/ar8000348.</cite> [<a href="https://doi.org/10.1021/ar8000348" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2645958/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18720952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acc%20Chem%20Res&title=The%20pursuit%20of%20a%20scalable%20nanofabrication%20platform%20for%20use%20in%20material%20and%20life%20science%20applications&author=SE%20Gratton&author=SS%20Williams&author=ME%20Napier&volume=41&publication_year=2008&pages=1685-95&pmid=18720952&doi=10.1021/ar8000348&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R121"> <span class="label">121.</span><cite>Gobin AM, Watkins EM, Quevedo E, et al. Near-Infrared-Resonant Gold/Gold Sulfide Nanoparticles as a Photothermal Cancer Therapeutic Agent. Small. 2010;6:745–52. doi: 10.1002/smll.200901557.</cite> [<a href="https://doi.org/10.1002/smll.200901557" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3014644/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20183810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Small&title=Near-Infrared-Resonant%20Gold/Gold%20Sulfide%20Nanoparticles%20as%20a%20Photothermal%20Cancer%20Therapeutic%20Agent&author=AM%20Gobin&author=EM%20Watkins&author=E%20Quevedo&volume=6&publication_year=2010&pages=745-52&pmid=20183810&doi=10.1002/smll.200901557&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R122"> <span class="label">122.</span><cite>Fonseca MJ, Jagtenberg JC, Haisma HJ, Storm G. Liposome-mediated targeting of enzymes to cancer cells for site-specific activation of prodrugs: comparison with the corresponding antibody-enzyme conjugate. Pharm Res. 2003;20:423–8. doi: 10.1023/a:1022608321861.</cite> [<a href="https://doi.org/10.1023/a:1022608321861" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12669963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharm%20Res&title=Liposome-mediated%20targeting%20of%20enzymes%20to%20cancer%20cells%20for%20site-specific%20activation%20of%20prodrugs:%20comparison%20with%20the%20corresponding%20antibody-enzyme%20conjugate&author=MJ%20Fonseca&author=JC%20Jagtenberg&author=HJ%20Haisma&author=G%20Storm&volume=20&publication_year=2003&pages=423-8&pmid=12669963&doi=10.1023/a:1022608321861&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R123"> <span class="label">123.</span><cite>Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release. 2002;82:189–212. doi: 10.1016/s0168-3659(02)00009-3.</cite> [<a href="https://doi.org/10.1016/s0168-3659(02)00009-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12175737/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Control%20Release&title=Pluronic%20block%20copolymers%20as%20novel%20polymer%20therapeutics%20for%20drug%20and%20gene%20delivery&author=AV%20Kabanov&author=EV%20Batrakova&author=VY%20Alakhov&volume=82&publication_year=2002&pages=189-212&pmid=12175737&doi=10.1016/s0168-3659(02)00009-3&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R124"> <span class="label">124.</span><cite>Wong HL, Rauth AM, Bendayan R, Wu XY. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model. Eur J Pharm Biopharm. 2007;65:300–8. doi: 10.1016/j.ejpb.2006.10.022.</cite> [<a href="https://doi.org/10.1016/j.ejpb.2006.10.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17156986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Pharm%20Biopharm&title=In%20vivo%20evaluation%20of%20a%20new%20polymer-lipid%20hybrid%20nanoparticle%20(PLN)%20formulation%20of%20doxorubicin%20in%20a%20murine%20solid%20tumor%20model&author=HL%20Wong&author=AM%20Rauth&author=R%20Bendayan&author=XY%20Wu&volume=65&publication_year=2007&pages=300-8&pmid=17156986&doi=10.1016/j.ejpb.2006.10.022&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R125"> <span class="label">125.</span><cite>Farokhzad OC, Cheng J, Teply BA, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA. 2006;103:6315–20. doi: 10.1073/pnas.0601755103.</cite> [<a href="https://doi.org/10.1073/pnas.0601755103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1458875/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16606824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20USA&title=Targeted%20nanoparticle-aptamer%20bioconjugates%20for%20cancer%20chemotherapy%20in%20vivo&author=OC%20Farokhzad&author=J%20Cheng&author=BA%20Teply&volume=103&publication_year=2006&pages=6315-20&pmid=16606824&doi=10.1073/pnas.0601755103&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R126"> <span class="label">126.</span><cite>Raffaghello L, Zuccari G, Carosio R, et al. In vitro and in vivo antitumor activity of the novel derivatized polyvinyl alcohol-based polymer P10(4) Clin Cancer Res. 2006;12:3485–93. doi: 10.1158/1078-0432.CCR-05-2318.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-05-2318" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16740774/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=In%20vitro%20and%20in%20vivo%20antitumor%20activity%20of%20the%20novel%20derivatized%20polyvinyl%20alcohol-based%20polymer%20P10(4)&author=L%20Raffaghello&author=G%20Zuccari&author=R%20Carosio&volume=12&publication_year=2006&pages=3485-93&pmid=16740774&doi=10.1158/1078-0432.CCR-05-2318&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R127"> <span class="label">127.</span><cite>Kukowska-Latallo JF, Candido KA, Cao Z, et al. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005;65:5317–24. doi: 10.1158/0008-5472.CAN-04-3921.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-04-3921" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15958579/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&title=Nanoparticle%20targeting%20of%20anticancer%20drug%20improves%20therapeutic%20response%20in%20animal%20model%20of%20human%20epithelial%20cancer&author=JF%20Kukowska-Latallo&author=KA%20Candido&author=Z%20Cao&volume=65&publication_year=2005&pages=5317-24&pmid=15958579&doi=10.1158/0008-5472.CAN-04-3921&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R128"> <span class="label">128.</span><cite>Morgan MT, Nakanishi Y, Kroll DJ, et al. Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro. Cancer Res. 2006;66:11913–21. doi: 10.1158/0008-5472.CAN-06-2066.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-06-2066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17178889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&title=Dendrimer-encapsulated%20camptothecins:%20increased%20solubility,%20cellular%20uptake,%20and%20cellular%20retention%20affords%20enhanced%20anticancer%20activity%20in%20vitro&author=MT%20Morgan&author=Y%20Nakanishi&author=DJ%20Kroll&volume=66&publication_year=2006&pages=11913-21&pmid=17178889&doi=10.1158/0008-5472.CAN-06-2066&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R129"> <span class="label">129.</span><cite>Wosikowski K, Biedermann E, Rattel B, et al. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells. Clin Cancer Res. 2003;9:1917–26.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/12738750/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=In%20vitro%20and%20in%20vivo%20antitumor%20activity%20of%20methotrexate%20conjugated%20to%20human%20serum%20albumin%20in%20human%20cancer%20cells&author=K%20Wosikowski&author=E%20Biedermann&author=B%20Rattel&volume=9&publication_year=2003&pages=1917-26&pmid=12738750&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R130"> <span class="label">130.</span><cite>Chavanpatil MD, Khdair A, Panyam J. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules. Pharm Res. 2007;24:803–10. doi: 10.1007/s11095-006-9203-2.</cite> [<a href="https://doi.org/10.1007/s11095-006-9203-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17318416/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharm%20Res&title=Surfactant-polymer%20nanoparticles:%20a%20novel%20platform%20for%20sustained%20and%20enhanced%20cellular%20delivery%20of%20water-soluble%20molecules&author=MD%20Chavanpatil&author=A%20Khdair&author=J%20Panyam&volume=24&publication_year=2007&pages=803-10&pmid=17318416&doi=10.1007/s11095-006-9203-2&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R131"> <span class="label">131.</span><cite>Hyung PJ, Kwon S, Lee M, et al. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. Biomater. 2006;27:119–26. doi: 10.1016/j.biomaterials.2005.05.028.</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2005.05.028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16023198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomater&title=Self-assembled%20nanoparticles%20based%20on%20glycol%20chitosan%20bearing%20hydrophobic%20moieties%20as%20carriers%20for%20doxorubicin:%20in%20vivo%20biodistribution%20and%20anti-tumor%20activity&author=PJ%20Hyung&author=S%20Kwon&author=M%20Lee&volume=27&publication_year=2006&pages=119-26&pmid=16023198&doi=10.1016/j.biomaterials.2005.05.028&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R132"> <span class="label">132.</span><cite>Everts M, Saini V, Leddon JL, et al. Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy. Nano Lett. 2006;6:587–91. doi: 10.1021/nl0500555.</cite> [<a href="https://doi.org/10.1021/nl0500555" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16608249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20Lett&title=Covalently%20linked%20Au%20nanoparticles%20to%20a%20viral%20vector:%20potential%20for%20combined%20photothermal%20and%20gene%20cancer%20therapy&author=M%20Everts&author=V%20Saini&author=JL%20Leddon&volume=6&publication_year=2006&pages=587-91&pmid=16608249&doi=10.1021/nl0500555&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R133"> <span class="label">133.</span><cite>Hirsch LR, Stafford RJ, Bankson JA, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA. 2003;100:13549–54. doi: 10.1073/pnas.2232479100.</cite> [<a href="https://doi.org/10.1073/pnas.2232479100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC263851/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14597719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20USA&title=Nanoshell-mediated%20near-infrared%20thermal%20therapy%20of%20tumors%20under%20magnetic%20resonance%20guidance&author=LR%20Hirsch&author=RJ%20Stafford&author=JA%20Bankson&volume=100&publication_year=2003&pages=13549-54&pmid=14597719&doi=10.1073/pnas.2232479100&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="R134"> <span class="label">134.</span><cite>Roy I, Ohulchanskyy TY, Pudavar HE, et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc. 2003;125:7860–5. doi: 10.1021/ja0343095.</cite> [<a href="https://doi.org/10.1021/ja0343095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12823004/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Chem%20Soc&title=Ceramic-based%20nanoparticles%20entrapping%20water-insoluble%20photosensitizing%20anticancer%20drugs:%20a%20novel%20drug-carrier%20system%20for%20photodynamic%20therapy&author=I%20Roy&author=TY%20Ohulchanskyy&author=HE%20Pudavar&volume=125&publication_year=2003&pages=7860-5&pmid=12823004&doi=10.1021/ja0343095&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> </ul></section></section></section></section></article> </main> </div> </div> </div>  <div class="pmc-sidenav desktop:grid-col-4 display-flex"> <section class="pmc-sidenav__container" aria-label="Article resources and navigation"> <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled"> <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" /> </button> <div class="display-none desktop:display-block"> <section class="margin-top-4 desktop:margin-top-0"> <h2 class="margin-top-0">ACTIONS</h2> <ul class="usa-list usa-list--unstyled usa-list--actions"> <li> <a href="https://doi.org/10.1517/17425247.2010.502560" class="usa-button usa-button--outline width-24 font-xs usa-link--external padding-left-0 padding-right-0" target="_blank" rel="noreferrer noopener" data-ga-category="actions" data-ga-action="click" data-ga-label="publisher_link_desktop" > <span class="height-3 display-inline-flex flex-align-center">View on publisher site</span> </a> </li> <li> <a href="pdf/nihms214788.pdf" class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1" data-ga-category="actions" data-ga-action="click" data-ga-label="pdf_download_desktop" > <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/sprite.svg#file_download"></use> </svg> <span class="display-inline-flex flex-justify-center flex-1">PDF (347.2 KB)</span> </a> </li> <li> <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1" aria-label="Open dialog with citation text in different styles" data-ga-category="actions" data-ga-action="open" data-ga-label="cite_desktop" data-all-citations-url="/resources/citations/2924765/" data-citation-style="nlm" data-download-format-link="/resources/citations/2924765/export/" > <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/sprite.svg#format_quote"></use> </svg> <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span> </button> </li> <li> <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty" aria-label="Save article in MyNCBI collections." data-ga-category="actions" data-ga-action="click" data-ga-label="collections_button_desktop" data-collections-open-dialog-enabled="false" data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC2924765%2F%23open-collections-dialog" data-in-collections="false"> <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use> </svg> <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use> </svg> <span class="display-inline-flex flex-justify-center flex-1">Collections</span> </button> </li> <li class="pmc-permalink"> <button type="button" class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none" aria-label="Show article permalink" aria-expanded="false" aria-haspopup="true" data-ga-category="actions" data-ga-action="open" data-ga-label="permalink_desktop" > <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/sprite.svg#share"></use> </svg> <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span> </button> <div class="pmc-permalink__dropdown" hidden> <div class="pmc-permalink__dropdown__container"> <h2 class="usa-modal__heading margin-top-0 margin-bottom-2">PERMALINK</h2> <div class="pmc-permalink__dropdown__content"> <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC2924765/" aria-label="Article permalink"> <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link"> <svg class="usa-icon" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#content_copy"></use> </svg> <span class="margin-left-1">Copy</span> </button> </div> </div> </div> </li> </ul> </section> </div> <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC2924765/"> <h2 class="margin-top-0">RESOURCES</h2> <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple> <h3 class="usa-accordion__heading"> <button type="button" class="usa-accordion__button" aria-expanded="false" aria-controls="resources-similar-articles" data-ga-category="resources_accordion" data-ga-action="open_similar_articles" data-ga-label="/articles/PMC2924765/" data-action-open="open_similar_articles" data-action-close="close_similar_articles" > Similar articles </button> </h3> <div id="resources-similar-articles" class="usa-accordion__content usa-prose" data-source-url="/resources/similar-article-links/20716019/" > </div> <h3 class="usa-accordion__heading"> <button type="button" class="usa-accordion__button" aria-expanded="false" aria-controls="resources-cited-by-other-articles" data-ga-category="resources_accordion" data-ga-action="open_cited_by" data-ga-label="/articles/PMC2924765/" data-action-open="open_cited_by" data-action-close="close_cited_by" > Cited by other articles </button> </h3> <div id="resources-cited-by-other-articles" class="usa-accordion__content usa-prose" data-source-url="/resources/cited-by-links/20716019/" > </div> <h3 class="usa-accordion__heading"> <button type="button" class="usa-accordion__button" aria-expanded="false" aria-controls="resources-links-to-ncbi-databases" data-ga-category="resources_accordion" data-ga-action="open_NCBI_links" data-ga-label="/articles/PMC2924765/" data-action-open="open_NCBI_links" data-action-close="close_NCBI_link" > Links to NCBI Databases </button> </h3> <div id="resources-links-to-ncbi-databases" class="usa-accordion__content usa-prose" data-source-url="/resources/db-links/2924765/" > </div> </div> </section> <section class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4" data-title-text="On this page" data-title-heading-level="h2" data-scroll-offset="0" data-root-margin="-10% 0px -80% 0px" data-main-content-selector="main" data-threshold="1" hidden ></section> </section> </div> <div class="overlay" role="dialog" aria-label="Citation Dialog" hidden> <div class="dialog citation-dialog" aria-hidden="true"> <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2"> <h2 class="usa-modal__heading margin-0">Cite</h2> <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto" tabindex="1"> <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#close"></use> </svg> </button> </div> <div class="citation-text-block"> <div class="citation-text margin-bottom-2"></div> <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center"> <li> <button class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus" data-ga-category="save_share" data-ga-action="cite" data-ga-label="copy" tabindex="2"> <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#content_copy"></use> </svg> <span>Copy</span> </button> </li> <li> <a href="#" role="button" class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button" data-ga-category="save_share" data-ga-action="cite" data-ga-label="download" title="Download a file for external citation management software" tabindex="3"> <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#file_download"></use> </svg> <span class="display-none mobile-lg:display-inline">Download .nbib</span> <span class="display-inline mobile-lg:display-none">.nbib</span> </a> </li> <li> <div class="display-inline-flex flex-align-center"> <label class="usa-label margin-top-0">Format:</label> <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" > <option data-style-url-name="ama" value="AMA" > AMA </option> <option data-style-url-name="apa" value="APA" > APA </option> <option data-style-url-name="mla" value="MLA" > MLA </option> <option data-style-url-name="nlm" value="NLM" selected="selected"> NLM </option> </select> </div> </li> </ul> </div> </div> </div> <div class="overlay" role="dialog" hidden> <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true"> <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2"> <h2 class="usa-modal__heading margin-0">Add to Collections</h2> </div> <div class="collections-action-panel action-panel"> <form id="collections-action-dialog-form" class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors" data-existing-collections-url="/list-existing-collections/" data-add-to-existing-collection-url="/add-to-existing-collection/" data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/" data-myncbi-max-collection-name-length="100" data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/"> <input type="hidden" name="csrfmiddlewaretoken" value="wadu9BCNIhrtuNiOkLoNahCsUxb6FkpF8OpDp1W585pWnYXhMWegAfzDkeMmHVbJ"> <fieldset class="usa-fieldset margin-bottom-2"> <div class="usa-radio"> <input type="radio" id="collections-action-dialog-new" class="usa-radio__input usa-radio__input--tile collections-new margin-top-0" name="collections" value="new" data-ga-category="collections_button" data-ga-action="click" data-ga-label="collections_radio_new" /> <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label> </div> <div class="usa-radio"> <input type="radio" id="collections-action-dialog-existing" class="usa-radio__input usa-radio__input--tile collections-existing" name="collections" value="existing" checked="true" data-ga-category="collections_button" data-ga-action="click" data-ga-label="collections_radio_existing" /> <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label> </div> </fieldset> <fieldset class="usa-fieldset margin-bottom-2"> <div class="action-panel-control-wrap new-collections-controls"> <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0"> Name your collection <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr> </label> <input type="text" name="add-to-new-collection" id="collections-action-dialog-add-to-new" class="usa-input collections-action-add-to-new" pattern="[^"&=<>/]*" title="The following characters are not allowed in the Name field: "&=<>/" maxlength="" data-ga-category="collections_button" data-ga-action="create_collection" data-ga-label="non_favorties_collection" required /> </div> <div class="action-panel-control-wrap existing-collections-controls"> <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0"> Choose a collection </label> <select id="collections-action-dialog-add-to-existing" class="usa-select collections-action-add-to-existing" data-ga-category="collections_button" data-ga-action="select_collection" data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'"> </select> <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message"> Unable to load your collection due to an error<br> <a href="#">Please try again</a> </div> </div> </fieldset> <div class="display-inline-flex"> <button class="usa-button margin-top-0 action-panel-submit" type="submit" data-loading-label="Adding..." data-pinger-ignore data-ga-category="collections_button" data-ga-action="click" data-ga-label="add"> Add </button> <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel" aria-label="Close 'Add to Collections' panel" ref="linksrc=close_collections_panel" data-ga-category="collections_button" data-ga-action="click" data-ga-label="cancel"> Cancel </button> </div> </form> </div> </div> </div> </div> </div> </div> <footer class="ncbi-footer ncbi-dark-background " > <div class="ncbi-footer__icon-section"> <div class="ncbi-footer__social-header"> Follow NCBI </div> <div class="grid-container ncbi-footer__ncbi-social-icons-container"> <a href="https://twitter.com/ncbi" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="40" height="40" viewBox="0 0 40 40" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z"> </path> </svg> <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span> </a> <a href="https://www.facebook.com/ncbi.nlm" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="16" height="29" focusable="false" aria-hidden="true" viewBox="0 0 16 29" fill="none" xmlns="http://www.w3.org/2000/svg"> <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z"> </path> </svg> <span class="usa-sr-only">NCBI on Facebook</span> </a> <a href="https://www.linkedin.com/company/ncbinlm" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="25" height="23" viewBox="0 0 26 24" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z"> </path> <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z"> </path> <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z"> </path> </svg> <span class="usa-sr-only">NCBI on LinkedIn</span> </a> <a href="https://github.com/ncbi" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="28" height="27" viewBox="0 0 28 28" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z"> </path> </svg> <span class="usa-sr-only">NCBI on GitHub</span> </a> <a href="https://ncbiinsights.ncbi.nlm.nih.gov/" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="26" height="26" viewBox="0 0 27 27" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z"> </path> <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z"> </path> <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z"> </path> </svg> <span class="usa-sr-only">NCBI RSS feed</span> </a> </div> </div> <div data-testid="gridContainer" class="grid-container ncbi-footer__container"> <div class="grid-row ncbi-footer__main-content-container" data-testid="grid"> <div class="ncbi-footer__column"> <p class="ncbi-footer__circled-icons-heading"> Connect with NLM </p> <div class="ncbi-footer__circled-icons-list"> <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener"> <svg width="32" height="32" viewBox="0 0 40 40" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z"> </path> </svg> <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span> </a> <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener"> <svg width="13" height="24" viewBox="0 0 13 24" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z"> </path> </svg> <span class="usa-sr-only">NLM on Facebook</span> </a> <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener"> <svg width="21" height="15" viewBox="0 0 21 15" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z" fill="white" /> </svg> <span class="usa-sr-only">NLM on YouTube</span> </a> </div> </div> <address class="ncbi-footer__address ncbi-footer__column"> <p> <a class="usa-link usa-link--external" href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508, -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508! 4d-77.0988323" rel="noopener noreferrer" target="_blank">National Library of Medicine <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a> </p> </address> <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column"> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link usa-link--alt ncbi-footer__link" > Web Policies </a> </li> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link usa-link--alt ncbi-footer__link" > FOIA </a> </li> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' > HHS Vulnerability Disclosure </a> </li> </ul> <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column"> <li class="ncbi-footer__vertical-list-item"> <a href="https://support.nlm.nih.gov/" class="usa-link usa-link--alt ncbi-footer__link" > Help </a> </li> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link usa-link--alt ncbi-footer__link" > Accessibility </a> </li> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link usa-link--alt ncbi-footer__link" > Careers </a> </li> </ul> </div> <div class="grid-row grid-col-12" data-testid="grid"> <ul class="ncbi-footer__bottom-links-list"> <li class="ncbi-footer__bottom-list-item"> <a href="https://www.nlm.nih.gov/" class="usa-link usa-link--alt ncbi-footer__link" > NLM </a> </li> <li class="ncbi-footer__bottom-list-item"> <a href="https://www.nih.gov/" class="usa-link usa-link--alt ncbi-footer__link" > NIH </a> </li> <li class="ncbi-footer__bottom-list-item"> <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' > HHS </a> </li> <li class="ncbi-footer__bottom-list-item"> <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' > USA.gov </a> </li> </ul> </div> </div> </footer> <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script> <button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top"> <label>Back to Top</label> <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#arrow_upward"></use> </svg> </button> <script src="https://code.jquery.com/jquery-3.5.0.min.js" integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ=" crossorigin="anonymous"> </script> <script type="text/javascript">var exports = {};</script> <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script> <script type="application/javascript"> window.ncbi = window.ncbi || {}; window.ncbi.pmc = window.ncbi.pmc || {}; window.ncbi.pmc.options = { logLevel: 'INFO', staticEndpoint: '/static/', citeCookieName: 'pmc-cf', }; </script> <script type="module" crossorigin="" src="/static/assets/base-9bea7450.js"></script> <script type="module" crossorigin="" src="/static/assets/article-722d91a2.js"></script> </body> </html>

CINXE.COM

Zinc Oxide Nanoparticles for Selective Destruction of Tumor Cells and Potential for Drug Delivery Applications - PMC